<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="with Hematological Malignancies978-3-642-15741-7978-3-642-15742-4 pmcid: 711502221 doi: 10.1007/978-3-642-15742-4_21 : Article Common" exact="Viral" post="Pneumonia AzoulayElie142499-421142499-426elie.azoulay@sls.ap-hop-paris.fr[], grid.413328.f0000000123006614Service de Réanimation Médicale, Hôpital Saint Louis,"/>
 <result pre="Hematological Malignancies978-3-642-15741-7978-3-642-15742-4 pmcid: 711502221 doi: 10.1007/978-3-642-15742-4_21 : Article Common Viral" exact="Pneumonia" post="AzoulayElie142499-421142499-426elie.azoulay@sls.ap-hop-paris.fr[], grid.413328.f0000000123006614Service de Réanimation Médicale, Hôpital Saint Louis, SchnellDavid1_21LegoffJérôme2_21AzoulayÉlieelie.azoulay@sls.aphp.fr3_214_21[1_21],"/>
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="(WHO) declaration of COVID-19 as a global pandemic. Abstract Common" exact="respiratory" post="viruses are now recognised as true opportunistic respiratory pathogens"/>
 <result pre="Abstract Common respiratory viruses are now recognised as true opportunistic" exact="respiratory" post="pathogens in patients with haematological malignancies. The epidemiology of"/>
 <result pre="studied in immunocompromised hosts, but is probably closely related to" exact="viral" post="activity in immunocompetent hosts, who constitute the virus reservoir"/>
 <result pre="the virus reservoir for immunocompromised patients. In these patients, common" exact="respiratory" post="viruses may cause severe infections with higher rates of"/>
 <result pre="patients. In these patients, common respiratory viruses may cause severe" exact="infections" post="with higher rates of progression to pneumonia and mortality"/>
 <result pre="may cause severe infections with higher rates of progression to" exact="pneumonia" post="and mortality compared to immunocompetent individuals. Prolonged high-titre viral"/>
 <result pre="to pneumonia and mortality compared to immunocompetent individuals. Prolonged high-titre" exact="viral" post="shedding is common in patients with haematological malignancies and"/>
 <result pre="in patients with haematological malignancies and may enhance not only" exact="viral" post="transmission, but also the selection of resistant strains. Influenza"/>
 <result pre="transmission, but also the selection of resistant strains. Influenza and" exact="respiratory" post="syncytial virus (RSV) infections have been particularly well studied."/>
 <result pre="selection of resistant strains. Influenza and respiratory syncytial virus (RSV)" exact="infections" post="have been particularly well studied. They are associated with"/>
 <result pre="infections have been particularly well studied. They are associated with" exact="pneumonia" post="rates of about one-third for influenza and 30–40% for"/>
 <result pre="rates ranging from 15% to 30%. The exact mechanisms of" exact="pneumonia" post="related to these viruses remains unknown, but bacterial and"/>
 <result pre="mechanisms of pneumonia related to these viruses remains unknown, but" exact="bacterial" post="and fungal co-infections are frequent and must be carefully"/>
 <result pre="urgently needed to better define the optimal management of common" exact="viral pneumonia" post="in patients with haematological malignancies. The absence of proven"/>
 <result pre="needed to better define the optimal management of common viral" exact="pneumonia" post="in patients with haematological malignancies. The absence of proven"/>
 <result pre="of common viral pneumonia in patients with haematological malignancies. The" exact="absence of" post="proven effective treatments highlights the critical importance of prevention."/>
 <result pre="of proven effective treatments highlights the critical importance of prevention." exact="Viral" post="transmission may be interrupted by contact isolation with droplet"/>
 <result pre="with haematological malignancies, their relatives, and health care workers. Keywords" exact="Respiratory" post="Syncytial Virus Lower Respiratory Tract Infection Respiratory Syncytial Virus"/>
 <result pre="relatives, and health care workers. Keywords Respiratory Syncytial Virus Lower" exact="Respiratory" post="Tract Infection Respiratory Syncytial Virus Infection Respiratory Virus Haematopoietic"/>
 <result pre="and health care workers. Keywords Respiratory Syncytial Virus Lower Respiratory" exact="Tract" post="Infection Respiratory Syncytial Virus Infection Respiratory Virus Haematopoietic Stem"/>
 <result pre="health care workers. Keywords Respiratory Syncytial Virus Lower Respiratory Tract" exact="Infection" post="Respiratory Syncytial Virus Infection Respiratory Virus Haematopoietic Stem Cell"/>
 <result pre="care workers. Keywords Respiratory Syncytial Virus Lower Respiratory Tract Infection" exact="Respiratory" post="Syncytial Virus Infection Respiratory Virus Haematopoietic Stem Cell Transplantation"/>
 <result pre="Respiratory Syncytial Virus Lower Respiratory Tract Infection Respiratory Syncytial Virus" exact="Infection" post="Respiratory Virus Haematopoietic Stem Cell Transplantation Introduction Common respiratory"/>
 <result pre="Syncytial Virus Lower Respiratory Tract Infection Respiratory Syncytial Virus Infection" exact="Respiratory" post="Virus Haematopoietic Stem Cell Transplantation Introduction Common respiratory viruses"/>
 <result pre="Virus Infection Respiratory Virus Haematopoietic Stem Cell Transplantation Introduction Common" exact="respiratory" post="viruses are probably among the leading causes of community-acquired"/>
 <result pre="respiratory viruses are probably among the leading causes of community-acquired" exact="pneumonia" post="[1, 2] but, oddly enough, have long been underrecognised"/>
 <result pre="with HMs at the cost of increased opportunities for severe" exact="infections" post="[3–5]. Combined with the development of new diagnostic methods"/>
 <result pre="at the cost of increased opportunities for severe infections [3–5]." exact="Combined" post="with the development of new diagnostic methods and introduction"/>
 <result pre="new diagnostic methods and introduction of antiviral drugs, this increased" exact="infection" post="rate has rekindled interest in the effects of common"/>
 <result pre="infection rate has rekindled interest in the effects of common" exact="respiratory" post="viruses in patients with HMs. These viruses are now"/>
 <result pre="with HMs. These viruses are now recognised as true opportunistic" exact="respiratory" post="pathogens in immunocompromised hosts. Common Respiratory Viruses There is"/>
 <result pre="recognised as true opportunistic respiratory pathogens in immunocompromised hosts. Common" exact="Respiratory" post="Viruses There is no clear definition of common respiratory"/>
 <result pre="Common Respiratory Viruses There is no clear definition of common" exact="respiratory" post="virus. Viruses that consistently produce respiratory manifestations are considered"/>
 <result pre="clear definition of common respiratory virus. Viruses that consistently produce" exact="respiratory" post="manifestations are considered respiratory viruses. These include members of"/>
 <result pre="respiratory virus. Viruses that consistently produce respiratory manifestations are considered" exact="respiratory" post="viruses. These include members of the following families of"/>
 <result pre="[RSV], parainfluenza viruses [PIV], and human metapneumoviruses [MPV]), Coronaviridae (human" exact="respiratory" post="coronaviruses), and Picornaviridae (human rhinoviruses). Other viruses that cause"/>
 <result pre="respiratory coronaviruses), and Picornaviridae (human rhinoviruses). Other viruses that cause" exact="respiratory" post="manifestations in many, but not all, patients are considered"/>
 <result pre="respiratory manifestations in many, but not all, patients are considered" exact="respiratory" post="viruses because they are often associated with seasonal respiratory"/>
 <result pre="considered respiratory viruses because they are often associated with seasonal" exact="respiratory" post="events. Examples include Adenoviridae (adenoviruses) and some Picornaviridae (non-poliomyelitic"/>
 <result pre="chapter of this book focuses on newly discovered and emerging" exact="respiratory" post="viruses (avian influenza viruses, newly discovered coronaviruses, polyomaviruses KI"/>
 <result pre="KI and WU, human bocavirus, and mimivirus). CMV and Herpes" exact="pneumonia" post="will also be addressed by Dr. Chemaly and colleagues"/>
 <result pre="to bind to sialic acid-conjugated glycoproteins at the surface of" exact="respiratory" post="epithelium cells. NA plays a crucial role in viral"/>
 <result pre="of respiratory epithelium cells. NA plays a crucial role in" exact="viral" post="dissemination by releasing newly formed virions from host cells."/>
 <result pre="influenza A also infects most avian species [6]. Fig. 21.1" exact="Diffuse" post="alveolo-interstitial pneumonia in a PIV3-infected patient RSV and PIV"/>
 <result pre="also infects most avian species [6]. Fig. 21.1 Diffuse alveolo-interstitial" exact="pneumonia" post="in a PIV3-infected patient RSV and PIV types 1–4"/>
 <result pre="virus is believed to originate from birds [13]. Fig. 21.2" exact="Diffuse" post="alveolar consolidations in a patient co-infected with influenza and"/>
 <result pre="only natural host of these viruses [14, 16]. Fig. 21.3" exact="Thoracic" post="CT scan showing bronchiolitis pattern (bronchial wall thickening associated"/>
 <result pre="these viruses [14, 16]. Fig. 21.3 Thoracic CT scan showing" exact="bronchiolitis" post="pattern (bronchial wall thickening associated with ground-glass attenuation, interlobular"/>
 <result pre="[18]. Human coronaviruses 229E and OC43 were the predominant human" exact="respiratory" post="coronavirus strains before the recent identification of the new"/>
 <result pre="are the only natural hosts of these viruses. Epidemiology Common" exact="respiratory" post="viruses are ubiquitous pathogens that share a number of"/>
 <result pre="occur with a remarkable seasonal pattern. These seasonal variations in" exact="viral" post="activity occur only in temperate climates and tend to"/>
 <result pre="phenomenon is incompletely understood and may involve not only specific" exact="viral" post="characteristics, but also seasonal changes in living conditions [6]."/>
 <result pre="epidemiology of PIV4, since this virus is responsible for mild" exact="infections" post="and is therefore rarely identified [7]. Common respiratory viruses"/>
 <result pre="for mild infections and is therefore rarely identified [7]. Common" exact="respiratory" post="viruses typically cause infections in early childhood. Influenza C"/>
 <result pre="is therefore rarely identified [7]. Common respiratory viruses typically cause" exact="infections" post="in early childhood. Influenza C usually causes mild infections"/>
 <result pre="cause infections in early childhood. Influenza C usually causes mild" exact="infections" post="that lead to the acquisition of protective antibodies capable"/>
 <result pre="A and B are considerably more common and can cause" exact="disease" post="of greater severity, most notably in high-risk groups, such"/>
 <result pre="in high-risk groups, such as elderly people and patients with" exact="chronic" post="respiratory or cardiovascular conditions, chronic renal failure, diabetes mellitus,"/>
 <result pre="high-risk groups, such as elderly people and patients with chronic" exact="respiratory" post="or cardiovascular conditions, chronic renal failure, diabetes mellitus, or"/>
 <result pre="such as elderly people and patients with chronic respiratory or" exact="cardiovascular" post="conditions, chronic renal failure, diabetes mellitus, or immune deficiencies"/>
 <result pre="elderly people and patients with chronic respiratory or cardiovascular conditions," exact="chronic" post="renal failure, diabetes mellitus, or immune deficiencies [6]. It"/>
 <result pre="people and patients with chronic respiratory or cardiovascular conditions, chronic" exact="renal failure," post="diabetes mellitus, or immune deficiencies [6]. It is estimated"/>
 <result pre="patients with chronic respiratory or cardiovascular conditions, chronic renal failure," exact="diabetes mellitus," post="or immune deficiencies [6]. It is estimated that about"/>
 <result pre="the high occurrence rate results in a huge burden of" exact="disease" post="that has a severe socioeconomic impact [6]. Influenza viruses"/>
 <result pre="of death in the USA [26]. Influenza A and B" exact="infections" post="start in childhood and continue to occur throughout the"/>
 <result pre="the USA [26]. Influenza A and B infections start in" exact="childhood" post="and continue to occur throughout the life span, because"/>
 <result pre="[6]. The result is an influenza pandemic due to the" exact="absence of" post="protective immunity against the new virus. Progressive acquisition of"/>
 <result pre="to the absence of protective immunity against the new virus." exact="Progressive" post="acquisition of immunity against this new strain attenuates the"/>
 <result pre="the twenty-first century [6, 27]. RSV and PIV are typically" exact="infections" post="of early childhood [7]. RSV and, to a lesser"/>
 <result pre="[6, 27]. RSV and PIV are typically infections of early" exact="childhood" post="[7]. RSV and, to a lesser extent, PIV also"/>
 <result pre="span. These recurrences may be severe, especially in patients with" exact="chronic" post="respiratory conditions and in the elderly. The burden of"/>
 <result pre="These recurrences may be severe, especially in patients with chronic" exact="respiratory" post="conditions and in the elderly. The burden of RSV-related"/>
 <result pre="data are available on the specific epidemiological characteristics of common" exact="respiratory" post="viruses in patients with HMs. Reported incidence rates vary"/>
 <result pre="the type of patients enrolled, reasons for screening patients for" exact="respiratory" post="viruses and, most importantly, diagnostic methods used. Whatever the"/>
 <result pre="incidence, one can reasonably assume that attack rates of common" exact="respiratory" post="viruses in immunocompromised patients are closely related to the"/>
 <result pre="in immunocompromised patients are closely related to the prevalence of" exact="respiratory" post="viruses in the community, which serves as the viral"/>
 <result pre="of respiratory viruses in the community, which serves as the" exact="viral" post="reservoir for immunocompromised patients [31]. This has been confirmed"/>
 <result pre="been confirmed in recent studies showing that the occurrence of" exact="viral" post="respiratory diseases in the enrolled immunocompromised patients paralleled the"/>
 <result pre="confirmed in recent studies showing that the occurrence of viral" exact="respiratory" post="diseases in the enrolled immunocompromised patients paralleled the concomitant"/>
 <result pre="respiratory diseases in the enrolled immunocompromised patients paralleled the concomitant" exact="viral" post="activity in the community [32, 33]. Accordingly, influenza viruses"/>
 <result pre="cohorts of HM patients, each accounting for about one-third of" exact="viral" post="respiratory events [34–36]. PIV, Picornaviridae, and adenoviruses come next."/>
 <result pre="of HM patients, each accounting for about one-third of viral" exact="respiratory" post="events [34–36]. PIV, Picornaviridae, and adenoviruses come next. It"/>
 <result pre="accounted for a much higher proportion (up to 75%) of" exact="viral" post="respiratory events in the study by Martino et al."/>
 <result pre="for a much higher proportion (up to 75%) of viral" exact="respiratory" post="events in the study by Martino et al. conducted"/>
 <result pre="patients with HM deserves special attention. Similar to other common" exact="respiratory" post="viruses, adenoviruses cause primary infections in childhood, usually during"/>
 <result pre="special attention. Similar to other common respiratory viruses, adenoviruses cause" exact="primary" post="infections in childhood, usually during the first few years"/>
 <result pre="attention. Similar to other common respiratory viruses, adenoviruses cause primary" exact="infections" post="in childhood, usually during the first few years of"/>
 <result pre="of life. Adenoviruses may account for 5% to 10% of" exact="viral" post="respiratory infections in children [23], and also cause outbreaks"/>
 <result pre="life. Adenoviruses may account for 5% to 10% of viral" exact="respiratory" post="infections in children [23], and also cause outbreaks in"/>
 <result pre="Adenoviruses may account for 5% to 10% of viral respiratory" exact="infections" post="in children [23], and also cause outbreaks in closed"/>
 <result pre="A distinctive feature of adenoviruses is the ability to cause" exact="chronic" post="latent infection by persisting in lymphoepithelial tissues, most notably"/>
 <result pre="feature of adenoviruses is the ability to cause chronic latent" exact="infection" post="by persisting in lymphoepithelial tissues, most notably in the"/>
 <result pre="the focus of specific studies. Nevertheless, exogenous contamination, by the" exact="respiratory" post="or oro-faecal route, may be less important than reactivation"/>
 <result pre="important than reactivation of the latent virus [39]. Thus, adenoviral" exact="infections" post="in patients with HM may be related chiefly to"/>
 <result pre="chiefly to the level of immunosuppression and, perhaps, to unknown" exact="viral" post="factors driving reactivation, rather than to the level of"/>
 <result pre="viral factors driving reactivation, rather than to the level of" exact="viral" post="activity in the community. The epidemiologic characteristics of influenza,"/>
 <result pre="and PIV are particularly well known, perhaps in part because" exact="infections" post="with these viruses are considerably more common compared to"/>
 <result pre="epidemiology are still limited. Recent studies using rt-PCR detection of" exact="respiratory" post="viruses in patients with HM revealed a high incidence"/>
 <result pre="incidence of human MPV infections, similar to that of RSV" exact="infections" post="[30, 36]. In the near future, studies using molecular"/>
 <result pre="biology tools may help to clarify the epidemiology of common" exact="respiratory" post="viruses and may lead to a radical change in"/>
 <result pre="to a radical change in current concepts. Clinical Manifestations Common" exact="respiratory" post="virus infections have been studied chiefly in patients receiving"/>
 <result pre="radical change in current concepts. Clinical Manifestations Common respiratory virus" exact="infections" post="have been studied chiefly in patients receiving high-dose chemotherapy"/>
 <result pre="Compared with immunocompetent patients, several distinctive features have been reported." exact="Viral" post="shedding lasts longer and progression to pneumonia is more"/>
 <result pre="have been reported. Viral shedding lasts longer and progression to" exact="pneumonia" post="is more common [31]. Late airflow obstruction has been"/>
 <result pre="airflow obstruction has been reported in HSCT recipients [40]. Some" exact="respiratory" post="viruses are responsible for extra-respiratory manifestations. Although rare in"/>
 <result pre="manifestations might be more common in patients with HM. Common" exact="respiratory" post="viral infections in patients with HM are characterized by"/>
 <result pre="might be more common in patients with HM. Common respiratory" exact="viral" post="infections in patients with HM are characterized by prolonged"/>
 <result pre="be more common in patients with HM. Common respiratory viral" exact="infections" post="in patients with HM are characterized by prolonged viral"/>
 <result pre="viral infections in patients with HM are characterized by prolonged" exact="viral" post="shedding. A median duration of 2 weeks was found"/>
 <result pre="was found in most studies [30, 32, 33, 36]. However," exact="viral" post="shedding may last for months in some cases [41,"/>
 <result pre="a longer period than do adults [31]. This prolonged high-load" exact="viral" post="shedding is of critical importance, since it may enhance"/>
 <result pre="shedding is of critical importance, since it may enhance both" exact="viral" post="dissemination [43, 44] and the emergence of resistant strains"/>
 <result pre="exposure to antiviral drugs [41, 42]. As stated above, common" exact="respiratory" post="viruses have long been underrecognised in patients with HM."/>
 <result pre="with HM. In the 1990s, the first reports of common" exact="respiratory" post="virus infections focused on influenza and RSV [45–50]. In"/>
 <result pre="In the 1990s, the first reports of common respiratory virus" exact="infections" post="focused on influenza and RSV [45–50]. In these studies,"/>
 <result pre="on influenza and RSV [45–50]. In these studies, progression to" exact="pneumonia" post="occurred in about 75% of patients infected with influenza"/>
 <result pre="these striking observations may be a surge of interest in" exact="respiratory" post="viral infections in HM patients that led to the"/>
 <result pre="striking observations may be a surge of interest in respiratory" exact="viral" post="infections in HM patients that led to the publication"/>
 <result pre="observations may be a surge of interest in respiratory viral" exact="infections" post="in HM patients that led to the publication of"/>
 <result pre="studies had small numbers of patients and high rates of" exact="nosocomial infections." post="More recently, studies of large patient cohorts led to"/>
 <result pre="of large patient cohorts led to better characterization of influenza-related" exact="pneumonia" post="in patients with HM [29, 32–34]. About one-third of"/>
 <result pre="patients with HM [29, 32–34]. About one-third of patients develop" exact="lower" post="respiratory tract infection (LRTI). Although less common than in"/>
 <result pre="with HM [29, 32–34]. About one-third of patients develop lower" exact="respiratory" post="tract infection (LRTI). Although less common than in previous"/>
 <result pre="[29, 32–34]. About one-third of patients develop lower respiratory tract" exact="infection" post="(LRTI). Although less common than in previous reports, influenza-related"/>
 <result pre="infection (LRTI). Although less common than in previous reports, influenza-related" exact="pneumonia" post="remains a severe condition with a 15–30% mortality rate."/>
 <result pre="condition with a 15–30% mortality rate. As in immunocompetent hosts," exact="upper respiratory tract infection" post="(URTI) is almost always present and often precedes LRTI"/>
 <result pre="with a 15–30% mortality rate. As in immunocompetent hosts, upper" exact="respiratory" post="tract infection (URTI) is almost always present and often"/>
 <result pre="15–30% mortality rate. As in immunocompetent hosts, upper respiratory tract" exact="infection" post="(URTI) is almost always present and often precedes LRTI"/>
 <result pre="can be considered a useful argument supporting the diagnosis of" exact="respiratory" post="viral infection in patients with HM investigated for pneumonia"/>
 <result pre="be considered a useful argument supporting the diagnosis of respiratory" exact="viral infection" post="in patients with HM investigated for pneumonia [53]. However,"/>
 <result pre="considered a useful argument supporting the diagnosis of respiratory viral" exact="infection" post="in patients with HM investigated for pneumonia [53]. However,"/>
 <result pre="of respiratory viral infection in patients with HM investigated for" exact="pneumonia" post="[53]. However, the identification of a common respiratory virus"/>
 <result pre="investigated for pneumonia [53]. However, the identification of a common" exact="respiratory" post="virus does not exclude an associated bacterial or fungal"/>
 <result pre="of a common respiratory virus does not exclude an associated" exact="bacterial" post="or fungal infection. These co-infections are very frequent, occurring"/>
 <result pre="common respiratory virus does not exclude an associated bacterial or" exact="fungal infection." post="These co-infections are very frequent, occurring in 12–25% of"/>
 <result pre="are very frequent, occurring in 12–25% of cases of influenza-related" exact="pneumonia" post="[32, 34, 50]. There are no reports of extra-respiratory"/>
 <result pre="manifestations in patients with HM, although myocarditis, pericarditis, myositis, meningo-encephalitis," exact="Guillain-Barré syndrome," post="and Reye syndrome have been described in immunocompetent patients"/>
 <result pre="with HM, although myocarditis, pericarditis, myositis, meningo-encephalitis, Guillain-Barré syndrome, and" exact="Reye syndrome" post="have been described in immunocompetent patients [6, 54]. RSV-related"/>
 <result pre="HM, although myocarditis, pericarditis, myositis, meningo-encephalitis, Guillain-Barré syndrome, and Reye" exact="syndrome" post="have been described in immunocompetent patients [6, 54]. RSV-related"/>
 <result pre="syndrome have been described in immunocompetent patients [6, 54]. RSV-related" exact="pneumonia" post="is now believed to complicate about 30–40% of RSV"/>
 <result pre="pneumonia is now believed to complicate about 30–40% of RSV" exact="infections" post="in patients with HM [32, 34, 47]. Again, mortality"/>
 <result pre="clinical manifestation. No clear data on the incidence of concomitant" exact="bacterial" post="or fungal infections are available in the literature, and"/>
 <result pre="clear data on the incidence of concomitant bacterial or fungal" exact="infections" post="are available in the literature, and RSV-related pneumonia in"/>
 <result pre="or fungal infections are available in the literature, and RSV-related" exact="pneumonia" post="in patients with HM are often ascribed to viral"/>
 <result pre="RSV-related pneumonia in patients with HM are often ascribed to" exact="viral infection" post="[53]. However, bacterial co-infections were present in as many"/>
 <result pre="pneumonia in patients with HM are often ascribed to viral" exact="infection" post="[53]. However, bacterial co-infections were present in as many"/>
 <result pre="with HM are often ascribed to viral infection [53]. However," exact="bacterial" post="co-infections were present in as many as 30% of"/>
 <result pre="as 30% of patients in a large study of RSV" exact="infections" post="in immunocompetent individuals [55]. Bacterial or fungal co-infection may"/>
 <result pre="case reports [8, 56]. However, no extra-respiratory manifestations of RSV" exact="infection" post="have been described in immunocompromised patients. PIV infections have"/>
 <result pre="of RSV infection have been described in immunocompromised patients. PIV" exact="infections" post="have also been studied in patients with HM [34,"/>
 <result pre="also been studied in patients with HM [34, 57]. PIV" exact="type 3" post="was the cause in 90% of reported cases. In"/>
 <result pre="cause in 90% of reported cases. In these studies, PIV-related" exact="pneumonia" post="was comparable to influenza-related pneumonia, with about one third"/>
 <result pre="[57]. However, in a recent study using rt-PCR for routine" exact="respiratory" post="virus detection in HSCT recipients, PIV was found in"/>
 <result pre="respiratory virus detection in HSCT recipients, PIV was found in" exact="respiratory" post="samples of asymptomatic patients [30], whereas influenza, RSV, and"/>
 <result pre="the occurrence of neurologic manifestations (such as meningitis, encephalitis, and" exact="Guillain-Barré" post="syndrome) and myocarditis [58]. Such manifestations have not been"/>
 <result pre="neurologic manifestations (such as meningitis, encephalitis, and Guillain-Barré syndrome) and" exact="myocarditis" post="[58]. Such manifestations have not been reported in immunocompromised"/>
 <result pre="suggest that the recently discovered human MPV may induce severe" exact="pneumonia" post="in patients with HM [59–61]. To our knowledge, two"/>
 <result pre="and three prospective cohorts [30, 36, 64] describing human MPV" exact="infections" post="in patients with HM have been published. The small"/>
 <result pre="a 0–40% mortality rate) preclude definitive conclusions about human MPV-related" exact="pneumonia" post="in patients with HM. Although debated, the occurrence of"/>
 <result pre="in patients with HM. Although debated, the occurrence of asymptomatic" exact="viral" post="shedding may suggest lesser severity of human MPV-related pneumonia"/>
 <result pre="asymptomatic viral shedding may suggest lesser severity of human MPV-related" exact="pneumonia" post="compared to influenza and RSV [30, 65]. Two cases"/>
 <result pre="compared to influenza and RSV [30, 65]. Two cases of" exact="encephalitis" post="with human MPV detected in cerebrospinal fluid in immunocompetent"/>
 <result pre="Picornaviridae and Coronaviridae relies chiefly on molecular biology tools, only" exact="limited" post="data are available about their contribution to respiratory viral"/>
 <result pre="tools, only limited data are available about their contribution to" exact="respiratory" post="viral infections in patients with HM. Epidemiological evidence supports"/>
 <result pre="only limited data are available about their contribution to respiratory" exact="viral" post="infections in patients with HM. Epidemiological evidence supports an"/>
 <result pre="limited data are available about their contribution to respiratory viral" exact="infections" post="in patients with HM. Epidemiological evidence supports an association"/>
 <result pre="growing evidence that human rhinovirus is able to replicate in" exact="lower" post="respiratory tract cells in vitro and in vivo [70,"/>
 <result pre="evidence that human rhinovirus is able to replicate in lower" exact="respiratory" post="tract cells in vitro and in vivo [70, 71],"/>
 <result pre="and in vivo [70, 71], whether this virus can cause" exact="pneumonia" post="remains debated [72]. Several reports in patients with HM"/>
 <result pre="retrospective studies in small patient populations with high rates of" exact="pulmonary" post="co-pathogen identification fail to demonstrate a clear role for"/>
 <result pre="are also principally responsible for URTI but may occasionally cause" exact="pneumonia" post="[81]. No studies have evaluated the role of Coronaviridae"/>
 <result pre="Although it is now clear that most of the common" exact="respiratory" post="viruses are responsible for an increased rate of pneumonia"/>
 <result pre="common respiratory viruses are responsible for an increased rate of" exact="pneumonia" post="in patients with HM (Table 21.1 and Fig. 21.1–21.3),"/>
 <result pre="and Fig. 21.1–21.3), the exact nature and causative mechanisms of" exact="pneumonia" post="in this situation remain unknown. The only risk factor"/>
 <result pre="this situation remain unknown. The only risk factor for virus-related" exact="pneumonia" post="found consistently in studies is lymphocytopenia, defined using a"/>
 <result pre="cells/mL) was independently associated with mortality in patients with influenza-related" exact="pneumonia" post="[34]. A higher incidence and greater severity of virus-related"/>
 <result pre="pneumonia [34]. A higher incidence and greater severity of virus-related" exact="pneumonia" post="have been noted in HSCT recipients compared with other"/>
 <result pre="with other patients with HM. This finding may reflect deeper" exact="lymphocyte depletion." post="However, in a study by Martino et al., pneumonia"/>
 <result pre="lymphocyte depletion. However, in a study by Martino et al.," exact="pneumonia" post="rates were comparable in patients with and without lymphocytopenia"/>
 <result pre="[32]. The possible higher incidence and greater severity of virus-related" exact="pneumonia" post="within the first few days after HSCT, compared with"/>
 <result pre="pneumonia within the first few days after HSCT, compared with" exact="infections" post="occurring later on, may reflect deeper lymphocyte depletion [53]."/>
 <result pre="HSCT, compared with infections occurring later on, may reflect deeper" exact="lymphocyte depletion" post="[53]. A similar mechanism may underlie the surprising protective"/>
 <result pre="al., since this treatment is often given to treat graft-versus-host" exact="disease" post="(GVHD) after lymphoid engraftment [33]. Table 21.1 Clinical manifestations"/>
 <result pre="after lymphoid engraftment [33]. Table 21.1 Clinical manifestations of influenza," exact="respiratory" post="syncytial virus (RSV), parainfluenza virus (PIV), human metapneumovirus (hMPV),"/>
 <result pre="in patients with haematological malignancies Influenza RSV PIV hMPV Adenovirus" exact="Pneumonia" post="rate (%) 33 30–40 Up to 30a Up to"/>
 <result pre="Yes Yes No NA not available aThe occurrence of asymptomatic" exact="viral" post="shedding may indicate lesser severity than previously thought Common"/>
 <result pre="viral shedding may indicate lesser severity than previously thought Common" exact="respiratory" post="viruses increase mortality in patients with HM mainly by"/>
 <result pre="but they may also contribute to a long-term decline in" exact="pulmonary" post="function. RSV, PIV, and influenza infections have been linked"/>
 <result pre="a long-term decline in pulmonary function. RSV, PIV, and influenza" exact="infections" post="have been linked to late airflow obstruction in HSCT"/>
 <result pre="[40]. In a study focusing specifically on the role of" exact="respiratory" post="viruses in late airflow obstruction, PIV LRTI was the"/>
 <result pre="was the strongest risk factor, followed by PIV URTI [84]." exact="Pneumonia" post="caused by RSV was a borderline-significant risk factor. The"/>
 <result pre="exact causative mechanisms remain unknown, but inflammation resulting from prolonged" exact="viral" post="persistence and pneumonia-induced post-acute-phase inflammation have been suggested as"/>
 <result pre="adenoviruses in HM patients is that they may either be" exact="acquired" post="via exogenous respiratory or oro-faecal contamination, or arise via"/>
 <result pre="patients is that they may either be acquired via exogenous" exact="respiratory" post="or oro-faecal contamination, or arise via reactivation of latent"/>
 <result pre="Adenoviruses cause a wide spectrum of clinical manifestations ranging from" exact="benign" post="conjunctivitis to rapidly fatal disseminated disease. In patients with"/>
 <result pre="cause a wide spectrum of clinical manifestations ranging from benign" exact="conjunctivitis" post="to rapidly fatal disseminated disease. In patients with HM,"/>
 <result pre="disease. In patients with HM, the risk of severe adenoviral" exact="disease" post="seems related to the level of immunosuppression. Adenoviral disease"/>
 <result pre="adenoviral disease seems related to the level of immunosuppression. Adenoviral" exact="disease" post="has been reported in 3–27% of HSCT recipients within"/>
 <result pre="T-cell depletion [86, 87, 91], lymphocytopenia [86], GVHD [87, 89]," exact="viral" post="shedding from more than one site [86, 88, 90],"/>
 <result pre="risk factors for severe adenoviral disease. Adenovirus viraemia consistently preceded" exact="viral" post="shedding from more than one site in the study"/>
 <result pre="of critical importance since it guides pre-emptive antiviral therapy. Adenoviral" exact="disease" post="has been chiefly reported in myeloablative HSCT recipients, but"/>
 <result pre="in non-myeloablative HSCT recipients, autologous transplant recipients, and patients with" exact="chronic" post="lymphocytic leukaemia treated with fludarabine combined with CD52 monoclonal"/>
 <result pre="HSCT recipients, autologous transplant recipients, and patients with chronic lymphocytic" exact="leukaemia" post="treated with fludarabine combined with CD52 monoclonal antibodies [88,"/>
 <result pre="In allogeneic transplant recipients, the most frequent manifestations of adenoviral" exact="infection" post="are gastrointestinal disease and haemorrhagic cystitis [95, 96]. Although"/>
 <result pre="transplant recipients, the most frequent manifestations of adenoviral infection are" exact="gastrointestinal disease" post="and haemorrhagic cystitis [95, 96]. Although haemorrhagic cystitis is"/>
 <result pre="recipients, the most frequent manifestations of adenoviral infection are gastrointestinal" exact="disease" post="and haemorrhagic cystitis [95, 96]. Although haemorrhagic cystitis is"/>
 <result pre="frequent manifestations of adenoviral infection are gastrointestinal disease and haemorrhagic" exact="cystitis" post="[95, 96]. Although haemorrhagic cystitis is a benign localised"/>
 <result pre="are gastrointestinal disease and haemorrhagic cystitis [95, 96]. Although haemorrhagic" exact="cystitis" post="is a benign localised event, it is associated with"/>
 <result pre="and haemorrhagic cystitis [95, 96]. Although haemorrhagic cystitis is a" exact="benign" post="localised event, it is associated with high morbidity [90]."/>
 <result pre="with febrile haematuria and adenovirus urinary excretion, the onset of" exact="acute" post="renal failure with flank pain may reveal adenovirus nephritis"/>
 <result pre="febrile haematuria and adenovirus urinary excretion, the onset of acute" exact="renal failure" post="with flank pain may reveal adenovirus nephritis [97]. Gastrointestinal"/>
 <result pre="of acute renal failure with flank pain may reveal adenovirus" exact="nephritis" post="[97]. Gastrointestinal manifestations include gastroenteritis and colitis, which often"/>
 <result pre="flank pain may reveal adenovirus nephritis [97]. Gastrointestinal manifestations include" exact="gastroenteritis" post="and colitis, which often manifest as febrile haemorrhagic diarrhoea"/>
 <result pre="manifestations include gastroenteritis and colitis, which often manifest as febrile" exact="haemorrhagic diarrhoea" post="[95, 98]. The most severe manifestations of adenoviral infection"/>
 <result pre="haemorrhagic diarrhoea [95, 98]. The most severe manifestations of adenoviral" exact="infection" post="are hepatitis, encephalitis, and pneumonia [86, 89, 90]. Adenovirus-related"/>
 <result pre="most severe manifestations of adenoviral infection are hepatitis, encephalitis, and" exact="pneumonia" post="[86, 89, 90]. Adenovirus-related pneumonia occurred in 15 of"/>
 <result pre="infection are hepatitis, encephalitis, and pneumonia [86, 89, 90]. Adenovirus-related" exact="pneumonia" post="occurred in 15 of the 85 patients with adenovirus"/>
 <result pre="pneumonia occurred in 15 of the 85 patients with adenovirus" exact="infection" post="in the study by La Rosa et al. [89]."/>
 <result pre="in the study by La Rosa et al. [89]. The" exact="pneumonia" post="was isolated in 11 patients and a manifestation of"/>
 <result pre="was isolated in 11 patients and a manifestation of disseminated" exact="disease" post="in 4 patients. Bacterial and fungal co-infections were found"/>
 <result pre="patients with isolated pneumonia, and 80% in patients with disseminated" exact="disease" post="[89]. Diagnosis Respiratory viral infections are the second most"/>
 <result pre="pneumonia, and 80% in patients with disseminated disease [89]. Diagnosis" exact="Respiratory" post="viral infections are the second most common cause of"/>
 <result pre="and 80% in patients with disseminated disease [89]. Diagnosis Respiratory" exact="viral" post="infections are the second most common cause of community-acquired"/>
 <result pre="80% in patients with disseminated disease [89]. Diagnosis Respiratory viral" exact="infections" post="are the second most common cause of community-acquired pneumonia"/>
 <result pre="viral infections are the second most common cause of community-acquired" exact="pneumonia" post="[2, 99]. They were long considered a simple differential"/>
 <result pre="practical consequences for the patient. Recently, however, the diagnosis of" exact="viral" post="respiratory infection has become increasingly relevant for medical care"/>
 <result pre="consequences for the patient. Recently, however, the diagnosis of viral" exact="respiratory" post="infection has become increasingly relevant for medical care [100,"/>
 <result pre="for the patient. Recently, however, the diagnosis of viral respiratory" exact="infection" post="has become increasingly relevant for medical care [100, 101]."/>
 <result pre="have been identified as significant causes of community-acquired and nosocomial" exact="respiratory" post="infections [29, 102]. Second, new nucleic acid-based assays have"/>
 <result pre="been identified as significant causes of community-acquired and nosocomial respiratory" exact="infections" post="[29, 102]. Second, new nucleic acid-based assays have been"/>
 <result pre="techniques. Third, specific antiviral drugs are now available for some" exact="respiratory" post="viruses, including influenza and adenovirus. Several diagnostic tests have"/>
 <result pre="Several diagnostic tests have been introduced for the detection of" exact="respiratory" post="viruses. The main characteristics of the most widely used"/>
 <result pre="shown in Table 21.2. Table 21.2 Methods for detecting common" exact="respiratory" post="viruses Test Sensitivity Specificity Time to result Viral targets"/>
 <result pre="detecting common respiratory viruses Test Sensitivity Specificity Time to result" exact="Viral" post="targets Cost Immunofluorescence staining ++ ++ &amp;lt;3 h &amp;lt;8"/>
 <result pre="clinical specimens are needed to ensure the accurate detection of" exact="respiratory" post="viruses. Indeed, respiratory virus detection requires a large number"/>
 <result pre="needed to ensure the accurate detection of respiratory viruses. Indeed," exact="respiratory" post="virus detection requires a large number of epithelial cells,"/>
 <result pre="viruses. Indeed, respiratory virus detection requires a large number of" exact="epithelial" post="cells, since viruses are intracellular pathogens. Nasopharyngeal aspirates and"/>
 <result pre="recognised to be superior to other sample types for detecting" exact="respiratory" post="viruses [103, 104]. Because the collection process is unpleasant"/>
 <result pre="requires a suction device, flocked swabs were recently introduced for" exact="respiratory" post="sample collection. Flocked swabs were found to improve the"/>
 <result pre="swabs were found to improve the collection and release of" exact="epithelial" post="cells [105, 106], and were recently recommended for the"/>
 <result pre="pandemic H1N1 influenza strain. The number of cells collected is" exact="lower" post="with flocked swabs than with nasopharyngeal aspirates, but seems"/>
 <result pre="flocked swabs than with nasopharyngeal aspirates, but seems sufficient for" exact="respiratory" post="virus detection by immunofluorescence [105, 106]. Flocked swab collection"/>
 <result pre="therefore constitute a good alternative to nasopharyngeal aspiration. Because most" exact="respiratory" post="viruses have high replication rates in the upper respiratory"/>
 <result pre="Because most respiratory viruses have high replication rates in the" exact="upper" post="respiratory tract, nasopharyngeal secretions are usually sufficient to diagnose"/>
 <result pre="most respiratory viruses have high replication rates in the upper" exact="respiratory" post="tract, nasopharyngeal secretions are usually sufficient to diagnose respiratory"/>
 <result pre="upper respiratory tract, nasopharyngeal secretions are usually sufficient to diagnose" exact="respiratory" post="viral infections. However, asymptomatic respiratory virus shedding in the"/>
 <result pre="respiratory tract, nasopharyngeal secretions are usually sufficient to diagnose respiratory" exact="viral" post="infections. However, asymptomatic respiratory virus shedding in the upper"/>
 <result pre="are usually sufficient to diagnose respiratory viral infections. However, asymptomatic" exact="respiratory" post="virus shedding in the upper respiratory tract may occur"/>
 <result pre="respiratory viral infections. However, asymptomatic respiratory virus shedding in the" exact="upper" post="respiratory tract may occur even in immunocompromised patients, and"/>
 <result pre="viral infections. However, asymptomatic respiratory virus shedding in the upper" exact="respiratory" post="tract may occur even in immunocompromised patients, and URTI"/>
 <result pre="detection have been the mainstay of clinical laboratory testing for" exact="respiratory" post="virus infections. Virus isolation required several cell lines and"/>
 <result pre="monoclonal antibodies were introduced to enable the detection of specific" exact="viral" post="antigens within 1–2 days. Direct or indirect fluorescent antibody"/>
 <result pre="days. Direct or indirect fluorescent antibody staining of cells from" exact="respiratory" post="specimens (mainly nasopharyngeal swabs or nasopharyngeal aspirates [NPA] and"/>
 <result pre="[NPA] and bronchoalveolar lavage fluid) is commonly used to detect" exact="viral" post="antigens. In many laboratories, the first-line test is immunofluorescence"/>
 <result pre="3 h. However commercial monoclonal antibodies are available for a" exact="limited" post="number of targets, including influenza A and B; RSV;"/>
 <result pre="gain in sensitivity and the ability to test for most" exact="respiratory" post="viruses, the need to carry out as many PCR"/>
 <result pre="to carry out as many PCR tests as targets has" exact="limited" post="the use of this method. None of the current"/>
 <result pre="Different technologies have been used. In addition, sensitivities may be" exact="lower" post="compared to monoplex real-time RT-PCR. Multiplex PCR procedures are"/>
 <result pre="primers characterized by a unique combination of optimal annealing conditions." exact="Multiple" post="primers included in a single tube may also result"/>
 <result pre="amplification. Currently, several multiplex assays can detect up to nine" exact="respiratory" post="viruses in a single reaction. Real-time multiplex assays detect"/>
 <result pre="cytometry [115, 116]. Multiplex ligation-dependent probe amplification (MLPA) involves specific" exact="viral" post="amplification followed by amplification after hybridisation and binding of"/>
 <result pre="using gel electrophoresis methods [117, 118]. Mass spectrometry assays for" exact="respiratory" post="virus detection are based on the analysis of base"/>
 <result pre="data are available on the exhaustive and sensitive detection of" exact="respiratory" post="viruses in HM patients. Recent data show that using"/>
 <result pre="studies of molecular assays in HSCT recipients documented persistent asymptomatic" exact="respiratory" post="shedding of PIV and human MPV [30, 65]. These"/>
 <result pre="the need for prospective studies of the molecular detection of" exact="respiratory" post="viruses to elucidate factors associated with symptomatic or asymptomatic"/>
 <result pre="molecular detection of respiratory viruses to elucidate factors associated with" exact="symptomatic" post="or asymptomatic respiratory viral infection and to help in"/>
 <result pre="respiratory viruses to elucidate factors associated with symptomatic or asymptomatic" exact="respiratory" post="viral infection and to help in the interpretation of"/>
 <result pre="viruses to elucidate factors associated with symptomatic or asymptomatic respiratory" exact="viral infection" post="and to help in the interpretation of positive assays"/>
 <result pre="to elucidate factors associated with symptomatic or asymptomatic respiratory viral" exact="infection" post="and to help in the interpretation of positive assays"/>
 <result pre="and rimantadine, act by inhibiting the M2 protein needed for" exact="viral" post="RNA release within the host cells. They are active"/>
 <result pre="duration with both drugs [123–125]. Neuraminidase inhibitors may also limit" exact="bacterial" post="super-infection of the lungs [125, 126]. Early administration of"/>
 <result pre="efficacy of neuraminidase inhibitors in patients with HM. The apparently" exact="lower" post="mortality in descriptive cohort studies compared with historical studies"/>
 <result pre="[33–35, 131]. Many of the patients in these cohorts had" exact="bacterial" post="and fungal co-infections, whose specific treatment probably contributed to"/>
 <result pre="have introduced a bias toward selection of patients with greater" exact="disease" post="severity. Given both the absence of strong evidence supporting"/>
 <result pre="selection of patients with greater disease severity. Given both the" exact="absence of" post="strong evidence supporting beneficial effects of neuraminidase inhibitor therapy"/>
 <result pre="inhibitors in these patients. Table 21.3 Antiviral treatments for common" exact="viral pneumonia" post="Oseltamivir Zanamivir Ribavirin Cidofovir Therapeutic class Neuraminidase inhibitor Neuraminidase"/>
 <result pre="in these patients. Table 21.3 Antiviral treatments for common viral" exact="pneumonia" post="Oseltamivir Zanamivir Ribavirin Cidofovir Therapeutic class Neuraminidase inhibitor Neuraminidase"/>
 <result pre="days 5 days 10 daysa Variableb Side effects Rash Rash" exact="bronchospasm" post="Haemolytic anaemiad bronchospasm Nephrotoxicityc myelosuppression retinitis Indication Influenza Influenza"/>
 <result pre="10 daysa Variableb Side effects Rash Rash bronchospasm Haemolytic anaemiad" exact="bronchospasm" post="Nephrotoxicityc myelosuppression retinitis Indication Influenza Influenza RSVe Adenoviruse Evidence"/>
 <result pre="Variableb Side effects Rash Rash bronchospasm Haemolytic anaemiad bronchospasm Nephrotoxicityc" exact="myelosuppression" post="retinitis Indication Influenza Influenza RSVe Adenoviruse Evidence supporting use"/>
 <result pre="Side effects Rash Rash bronchospasm Haemolytic anaemiad bronchospasm Nephrotoxicityc myelosuppression" exact="retinitis" post="Indication Influenza Influenza RSVe Adenoviruse Evidence supporting use Cohort"/>
 <result pre="cHyperhydratation and probenecide may help to prevent cidofovir nephrotoxicity dHaemolytic" exact="anaemia" post="may be readily controlled by blood transfusion eThese drugs"/>
 <result pre="indications Ribavirin is the only available antiviral drug for Paramyxoviridae" exact="infection" post="(Table 21.3). The efficacy of aerosolized ribavirin was variable"/>
 <result pre="(Table 21.3). The efficacy of aerosolized ribavirin was variable in" exact="uncontrolled" post="cohorts of patients with RSV-related pneumonia [34, 46, 132]."/>
 <result pre="ribavirin was variable in uncontrolled cohorts of patients with RSV-related" exact="pneumonia" post="[34, 46, 132]. Again, the results must be interpreted"/>
 <result pre="with caution. Early ribavirin therapy, introduced before the onset of" exact="respiratory" post="failure, seemed associated with lower mortality in the study"/>
 <result pre="introduced before the onset of respiratory failure, seemed associated with" exact="lower" post="mortality in the study by Whimbey et al. [132]."/>
 <result pre="by ribavirin treatment of RSV URTI to prevent progression to" exact="pneumonia" post="[133, 134]. The study by Boeckh et al. is"/>
 <result pre="controlled trial evaluating pre-emptive ribavirin therapy in patients with RSV" exact="infection" post="[133]. Unfortunately, the trial did not enrol a sufficient"/>
 <result pre="No clear efficacy of aerosolized ribavirin was found in small," exact="uncontrolled" post="cohorts of patients with HM [34, 139]. Early initiation"/>
 <result pre="ribavirin, either alone or combined with immunoglobulins, to treat Paramyxoviridae-related" exact="pneumonia" post="in patients with HM. No controlled randomised study has"/>
 <result pre="No controlled randomised study has evaluated the treatment of adenoviral" exact="disease" post="in patients with HM. Ribavirin and cidofovir have been"/>
 <result pre="been suggested for the treatment of adenoviral infections, but only" exact="uncontrolled" post="cohort studies are available to support their use. Intravenous"/>
 <result pre="(Table 21.3) seemed to result in better outcomes in small," exact="uncontrolled" post="series [148–153]. Ganciclovir and antiretroviral drugs, such as zalcitabine,"/>
 <result pre="the benefits from this treatment. The greater severity of common" exact="respiratory" post="viral infections in HM patients and the lack of"/>
 <result pre="benefits from this treatment. The greater severity of common respiratory" exact="viral" post="infections in HM patients and the lack of clearly"/>
 <result pre="from this treatment. The greater severity of common respiratory viral" exact="infections" post="in HM patients and the lack of clearly proven"/>
 <result pre="critical importance of preventive strategies. Prevention The occurrence of common" exact="respiratory" post="virus infections in patients with HM is closely related"/>
 <result pre="of preventive strategies. Prevention The occurrence of common respiratory virus" exact="infections" post="in patients with HM is closely related to viral"/>
 <result pre="virus infections in patients with HM is closely related to" exact="viral" post="activity in the community. However, nosocomial outbreaks have been"/>
 <result pre="[31, 43, 44, 46, 158–160]. Preventing nosocomial transmission of common" exact="respiratory" post="viruses requires a multifaceted approach (Table 21.4) that targets"/>
 <result pre="to originate from infected patients and from infected health-care workers." exact="Infection" post="control measures include screening symptomatic patients for common respiratory"/>
 <result pre="and from infected health-care workers. Infection control measures include screening" exact="symptomatic" post="patients for common respiratory viruses, early isolation of infected"/>
 <result pre="workers. Infection control measures include screening symptomatic patients for common" exact="respiratory" post="viruses, early isolation of infected patients, screening health-care workers"/>
 <result pre="isolation of infected patients, screening health-care workers and visitors for" exact="respiratory" post="symptoms, and avoiding contact of symptomatic individuals with patients."/>
 <result pre="workers and visitors for respiratory symptoms, and avoiding contact of" exact="symptomatic" post="individuals with patients. Most haematologic wards do not allow"/>
 <result pre="to visit patients, as children are highly prone to common" exact="respiratory" post="virus infections and may exhibit viral shedding long after"/>
 <result pre="patients, as children are highly prone to common respiratory virus" exact="infections" post="and may exhibit viral shedding long after symptom resolution"/>
 <result pre="highly prone to common respiratory virus infections and may exhibit" exact="viral" post="shedding long after symptom resolution [39]. Continual reinforcement of"/>
 <result pre="be enhanced by educational programs [161]. Most of the common" exact="respiratory" post="viruses are transmitted by droplets or direct contact of"/>
 <result pre="droplets or direct contact of infected secretions with the nasal" exact="mucosa" post="or conjunctiva. Indirect transmission via contaminated fomites or devices"/>
 <result pre="influenza transmission as masks with greater filtration capacity [165, 166]." exact="Infection" post="control measures have not been evaluated in randomised control"/>
 <result pre="suggests they may help to prevent the transmission of common" exact="respiratory" post="viruses [43]. It must be pointed out that asymptomatic"/>
 <result pre="respiratory viruses [43]. It must be pointed out that asymptomatic" exact="viral" post="shedding, when present, limits the effectiveness of infection control"/>
 <result pre="that asymptomatic viral shedding, when present, limits the effectiveness of" exact="infection" post="control measures [30, 65]. The optimal duration of isolation"/>
 <result pre="isolation should be prolonged in asymptomatic patients with persistent low-titre" exact="viral" post="shedding detected only by molecular methods remains unclear. Since"/>
 <result pre="acquisition is known to result also from endogenous reactivation, adenoviral" exact="infections" post="may be chiefly related to the level of immunosuppression"/>
 <result pre="86] and, therefore, may not be effectively prevented by standard" exact="infection" post="control measures. Table 21.4 Infection control measures for common"/>
 <result pre="be effectively prevented by standard infection control measures. Table 21.4" exact="Infection" post="control measures for common respiratory viruses Specific infection control"/>
 <result pre="infection control measures. Table 21.4 Infection control measures for common" exact="respiratory" post="viruses Specific infection control measures Screening patients for respiratory"/>
 <result pre="Table 21.4 Infection control measures for common respiratory viruses Specific" exact="infection" post="control measures Screening patients for respiratory virus infections Contact"/>
 <result pre="common respiratory viruses Specific infection control measures Screening patients for" exact="respiratory" post="virus infections Contact isolation with droplet precautions for infected"/>
 <result pre="viruses Specific infection control measures Screening patients for respiratory virus" exact="infections" post="Contact isolation with droplet precautions for infected patients Screening"/>
 <result pre="patients Health-care workers To date, influenza is the only common" exact="respiratory" post="virus for which a vaccine is available. Immunisation remains"/>
 <result pre="prevention [6]. The immunogenicity of the inactivated influenza vaccine is" exact="lower" post="in patients with HM compared with immunocompetent controls [167–172]."/>
 <result pre="virus [175]. Pharmacological interventions have been proposed to prevent common" exact="respiratory" post="virus infections. Intravenous immunoglobulins and palivizumab have been suggested"/>
 <result pre="infections. Intravenous immunoglobulins and palivizumab have been suggested for RSV" exact="infection" post="prevention, but have not been evaluated in patients with"/>
 <result pre="Another way to prevent morbidity and mortality related to common" exact="respiratory" post="viruses in patients with HM is to limit the"/>
 <result pre="the risk of progression to pneumonia. The pre-emptive treatment of" exact="viral" post="URTI has been discussed above. Given the severity of"/>
 <result pre="URTI has been discussed above. Given the severity of common" exact="respiratory" post="virus pneumonia in patients with HM, it appears logical"/>
 <result pre="been discussed above. Given the severity of common respiratory virus" exact="pneumonia" post="in patients with HM, it appears logical and prudent"/>
 <result pre="logical and prudent to postpone HSCT in patients with documented" exact="viral" post="infections. A retrospective cohort study suggested that this measure"/>
 <result pre="retrospective cohort study suggested that this measure might prevent RSV-related" exact="pneumonia" post="in patients undergoing HSCT [178]. It is unclear whether"/>
 <result pre="types of HSCT, to intensive chemotherapy courses, and for all" exact="respiratory" post="viruses. Conclusion Common respiratory viruses are now recognised as"/>
 <result pre="intensive chemotherapy courses, and for all respiratory viruses. Conclusion Common" exact="respiratory" post="viruses are now recognised as true opportunistic respiratory pathogens"/>
 <result pre="Conclusion Common respiratory viruses are now recognised as true opportunistic" exact="respiratory" post="pathogens in patients with HM. In these patients, they"/>
 <result pre="indicating a need for further investigations. The epidemiology of common" exact="respiratory" post="virus infections in patients with HM has not been"/>
 <result pre="need for further investigations. The epidemiology of common respiratory virus" exact="infections" post="in patients with HM has not been extensively studied."/>
 <result pre="has not been extensively studied. Large epidemiological studies of common" exact="respiratory" post="virus infections in patients with HM based on molecular"/>
 <result pre="been extensively studied. Large epidemiological studies of common respiratory virus" exact="infections" post="in patients with HM based on molecular biology tools"/>
 <result pre="changes in knowledge. Although it is now clear that common" exact="respiratory" post="viruses are responsible for increased pneumonia rates in patients"/>
 <result pre="now clear that common respiratory viruses are responsible for increased" exact="pneumonia" post="rates in patients with HM, the exact nature and"/>
 <result pre="with HM, the exact nature and causative mechanisms of these" exact="pneumonia" post="cases remain unknown. Studies are warranted to investigate the"/>
 <result pre="urgently needed. References References 1.FileTMCommunity-acquired pneumoniaLancet200336294001991200114683661 2.de RouxAet al.Viral community-acquired" exact="pneumonia" post="in nonimmunocompromised adultsChest200412541343135115078744 3.BrennerHLong-term survival rates of cancer patients"/>
 <result pre="al.Viral community-acquired pneumonia in nonimmunocompromised adultsChest200412541343135115078744 3.BrennerHLong-term survival rates of" exact="cancer" post="patients achieved by the end of the 20th century:"/>
 <result pre="plus rituximab compared with CHOP alone in elderly patients with" exact="diffuse" post="large-B-cell lymphomaN Engl J Med2002346423524211807147 5.NachmanJBet al.Augmented post-induction therapy"/>
 <result pre="J Med2002346423524211807147 5.NachmanJBet al.Augmented post-induction therapy for children with high-risk" exact="acute lymphoblastic leukemia" post="and a slow response to initial therapyN Engl J"/>
 <result pre="Med2002346423524211807147 5.NachmanJBet al.Augmented post-induction therapy for children with high-risk acute" exact="lymphoblastic leukemia" post="and a slow response to initial therapyN Engl J"/>
 <result pre="5.NachmanJBet al.Augmented post-induction therapy for children with high-risk acute lymphoblastic" exact="leukemia" post="and a slow response to initial therapyN Engl J"/>
 <result pre="initial therapyN Engl J Med199833823166316719614257 6.TreanorJJMandellGInfluenza virusPrinciples and practice of" exact="infectious" post="diseases20056Philadelphia, PAChurchill Livingston2060 7.HallCBRespiratory syncytial virus and parainfluenza virusN"/>
 <result pre="syncytial virus and parainfluenza virusN Engl J Med2001344251917192811419430 8.FalseyARWalshEERespiratory syncytial" exact="virus infection" post="in adultsClin Microbiol Rev200013337138410885982 9.HallCBMccarthyCAMandellGRespiratory Syncytial VirusPrinciples and practice"/>
 <result pre="virus and parainfluenza virusN Engl J Med2001344251917192811419430 8.FalseyARWalshEERespiratory syncytial virus" exact="infection" post="in adultsClin Microbiol Rev200013337138410885982 9.HallCBMccarthyCAMandellGRespiratory Syncytial VirusPrinciples and practice"/>
 <result pre="in adultsClin Microbiol Rev200013337138410885982 9.HallCBMccarthyCAMandellGRespiratory Syncytial VirusPrinciples and practice of" exact="infectious" post="diseases20056Philadelphia, PAChurchill Livingstone2008 10.WrightPFMandellGParainfluenza virusesPrinciples and practice of infectious"/>
 <result pre="of infectious diseases20056Philadelphia, PAChurchill Livingstone2008 10.WrightPFMandellGParainfluenza virusesPrinciples and practice of" exact="infectious" post="diseases20056Philadelphia, PAChurchill Livingstone1998 11.van den HoogenBGet al.A newly discovered"/>
 <result pre="al.A newly discovered human pneumovirus isolated from young children with" exact="respiratory" post="tract diseaseNat Med20017671972411385510 12.KahnJSEpidemiology of human metapneumovirusClin Microbiol Rev200619354655716847085"/>
 <result pre="of human metapneumovirusClin Microbiol Rev200619354655716847085 13.FalseyARMandellGHuman MetapneumovirusPrinciples and practice of" exact="infectious" post="diseases20056Philadelphia, PAChurchill Livingstone2027 14.GreenbergSBRespiratory consequences of rhinovirus infectionArch Intern"/>
 <result pre="(HRV C)PLoS ONE200834e184718382652 16.ModlinJFMandellGIntroduction to the EnterovirusesPrinciples and practice of" exact="infectious" post="diseases2005Philadelphia, PAChurchill Livingstone2141 17.StanwayGFauquetCMMayoMAManiloffJDesselbergerUBallLAFamily PicornaviridaeVirus taxonomy. Eighth report of"/>
 <result pre="International Committee on Taxonomy of Viruses2005LondonElsevier Academic Press757778 18.McintoshKAndersonLJMandellGCoronaviruses, Including" exact="Severe" post="Acute Respiratory Syndrome (SARS)-Associated CoronavirusPrinciples and practice of infectious"/>
 <result pre="Committee on Taxonomy of Viruses2005LondonElsevier Academic Press757778 18.McintoshKAndersonLJMandellGCoronaviruses, Including Severe" exact="Acute" post="Respiratory Syndrome (SARS)-Associated CoronavirusPrinciples and practice of infectious diseases20056Philadelphia,"/>
 <result pre="on Taxonomy of Viruses2005LondonElsevier Academic Press757778 18.McintoshKAndersonLJMandellGCoronaviruses, Including Severe Acute" exact="Respiratory" post="Syndrome (SARS)-Associated CoronavirusPrinciples and practice of infectious diseases20056Philadelphia, PAChurchill"/>
 <result pre="Taxonomy of Viruses2005LondonElsevier Academic Press757778 18.McintoshKAndersonLJMandellGCoronaviruses, Including Severe Acute Respiratory" exact="Syndrome" post="(SARS)-Associated CoronavirusPrinciples and practice of infectious diseases20056Philadelphia, PAChurchill Livingstone1990"/>
 <result pre="Including Severe Acute Respiratory Syndrome (SARS)-Associated CoronavirusPrinciples and practice of" exact="infectious" post="diseases20056Philadelphia, PAChurchill Livingstone1990 19.KuikenTet al.Newly discovered coronavirus as the"/>
 <result pre="infectious diseases20056Philadelphia, PAChurchill Livingstone1990 19.KuikenTet al.Newly discovered coronavirus as the" exact="primary" post="cause of severe acute respiratory syndromeLancet2003362938026327012892955 20.van der HoekLet"/>
 <result pre="19.KuikenTet al.Newly discovered coronavirus as the primary cause of severe" exact="acute" post="respiratory syndromeLancet2003362938026327012892955 20.van der HoekLet al.Identification of a new"/>
 <result pre="al.Newly discovered coronavirus as the primary cause of severe acute" exact="respiratory" post="syndromeLancet2003362938026327012892955 20.van der HoekLet al.Identification of a new human"/>
 <result pre="al.Identification of a new human coronavirusNat Med200410436837315034574 21.WooPCet al.Characterization and" exact="complete" post="genome sequence of a novel coronavirus, coronavirus HKU1, from"/>
 <result pre="of Viruses in Strasbourg, August 1981Intervirology19811653 23.BaumSGMandellGAdenovirusPrinciples and practice of" exact="infectious" post="diseases20056Philadelphia, PAChurchill Livingstone1624 24.MatsuzakiYet al.Clinical features of influenza C"/>
 <result pre="infectious diseases20056Philadelphia, PAChurchill Livingstone1624 24.MatsuzakiYet al.Clinical features of influenza C" exact="virus infection" post="in childrenJ Infect Dis200619391229123516586359 25.TurnerDet al.Systematic review and economic"/>
 <result pre="diseases20056Philadelphia, PAChurchill Livingstone1624 24.MatsuzakiYet al.Clinical features of influenza C virus" exact="infection" post="in childrenJ Infect Dis200619391229123516586359 25.TurnerDet al.Systematic review and economic"/>
 <result pre="(H1N1) virus in humansN Engl J Med2009360252605261519423869 28.FalseyARet al.Respiratory syncytial" exact="virus infection" post="in elderly and high-risk adultsN Engl J Med2005352171749175915858184 29.LjungmanPet"/>
 <result pre="virus in humansN Engl J Med2009360252605261519423869 28.FalseyARet al.Respiratory syncytial virus" exact="infection" post="in elderly and high-risk adultsN Engl J Med2005352171749175915858184 29.LjungmanPet"/>
 <result pre="elderly and high-risk adultsN Engl J Med2005352171749175915858184 29.LjungmanPet al.Respiratory virus" exact="infections" post="after stem cell transplantation: a prospective study from the"/>
 <result pre="infections after stem cell transplantation: a prospective study from the" exact="Infectious" post="Diseases Working Party of the European Group for Blood"/>
 <result pre="after stem cell transplantation: a prospective study from the Infectious" exact="Diseases" post="Working Party of the European Group for Blood and"/>
 <result pre="the Infectious Diseases Working Party of the European Group for" exact="Blood" post="and Marrow TransplantationBone Marrow Transplant200128547948411593321 30.PeckAJet al.Respiratory virus infection"/>
 <result pre="Group for Blood and Marrow TransplantationBone Marrow Transplant200128547948411593321 30.PeckAJet al.Respiratory" exact="virus infection" post="among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza"/>
 <result pre="for Blood and Marrow TransplantationBone Marrow Transplant200128547948411593321 30.PeckAJet al.Respiratory virus" exact="infection" post="among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza"/>
 <result pre="cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood200711051681168817502457 31.CouchRBEnglundJAWhimbeyERespiratory" exact="viral" post="infections in immunocompetent and immunocompromised personsAm J Med19971023A2910868136 32.MartinoRet"/>
 <result pre="transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood200711051681168817502457 31.CouchRBEnglundJAWhimbeyERespiratory viral" exact="infections" post="in immunocompetent and immunocompromised personsAm J Med19971023A2910868136 32.MartinoRet al.Respiratory"/>
 <result pre="in immunocompetent and immunocompromised personsAm J Med19971023A2910868136 32.MartinoRet al.Respiratory virus" exact="infections" post="in adults with hematologic malignancies: a prospective studyClin Infect"/>
 <result pre="with hematologic malignancies: a prospective studyClin Infect Dis20033611812491194 33.NicholsWGet al.Influenza" exact="infections" post="after hematopoietic stem cell transplantation: risk factors, mortality, and"/>
 <result pre="and the effect of antiviral therapyClin Infect Dis20043991300130615494906 34.ChemalyRFet al.Respiratory" exact="viral" post="infections in adults with hematologic malignancies and human stem"/>
 <result pre="the effect of antiviral therapyClin Infect Dis20043991300130615494906 34.ChemalyRFet al.Respiratory viral" exact="infections" post="in adults with hematologic malignancies and human stem cell"/>
 <result pre="stem cell transplantation recipients: a retrospective study at a major" exact="cancer" post="centerMedicine (Baltimore)200685527828716974212 35.MachadoCMet al.Low mortality rates related to respiratory"/>
 <result pre="major cancer centerMedicine (Baltimore)200685527828716974212 35.MachadoCMet al.Low mortality rates related to" exact="respiratory" post="virus infections after bone marrow transplantationBone Marrow Transplant200331869570012692610 36.MartinoRet"/>
 <result pre="centerMedicine (Baltimore)200685527828716974212 35.MachadoCMet al.Low mortality rates related to respiratory virus" exact="infections" post="after bone marrow transplantationBone Marrow Transplant200331869570012692610 36.MartinoRet al.Prospective study"/>
 <result pre="al.Prospective study of the incidence, clinical features, and outcome of" exact="symptomatic" post="upper and lower respiratory tract infections by respiratory viruses"/>
 <result pre="study of the incidence, clinical features, and outcome of symptomatic" exact="upper" post="and lower respiratory tract infections by respiratory viruses in"/>
 <result pre="the incidence, clinical features, and outcome of symptomatic upper and" exact="lower" post="respiratory tract infections by respiratory viruses in adult recipients"/>
 <result pre="incidence, clinical features, and outcome of symptomatic upper and lower" exact="respiratory" post="tract infections by respiratory viruses in adult recipients of"/>
 <result pre="features, and outcome of symptomatic upper and lower respiratory tract" exact="infections" post="by respiratory viruses in adult recipients of hematopoietic stem"/>
 <result pre="outcome of symptomatic upper and lower respiratory tract infections by" exact="respiratory" post="viruses in adult recipients of hematopoietic stem cell transplants"/>
 <result pre="upper and lower respiratory tract infections by respiratory viruses in" exact="adult" post="recipients of hematopoietic stem cell transplants for hematologic malignanciesBiol"/>
 <result pre="adult recipients of hematopoietic stem cell transplants for hematologic malignanciesBiol" exact="Blood" post="Marrow Transplant2005111078179616182179 37.Kolavic-GraySAet al.Large epidemic of adenovirus type 4"/>
 <result pre="hematologic malignanciesBiol Blood Marrow Transplant2005111078179616182179 37.Kolavic-GraySAet al.Large epidemic of adenovirus" exact="type 4" post="infection among military trainees: epidemiological, clinical, and laboratory studiesClin"/>
 <result pre="Blood Marrow Transplant2005111078179616182179 37.Kolavic-GraySAet al.Large epidemic of adenovirus type 4" exact="infection" post="among military trainees: epidemiological, clinical, and laboratory studiesClin Infect"/>
 <result pre="clinical, and laboratory studiesClin Infect Dis200235780881812228817 38.RyanMAet al.Large epidemic of" exact="respiratory" post="illness due to adenovirus types 7 and 3 in"/>
 <result pre="3 in healthy young adultsClin Infect Dis200234557758211803503 39.BoeckhMThe challenge of" exact="respiratory" post="virus infections in hematopoietic cell transplant recipientsBr J Haematol2008143445546718785968"/>
 <result pre="healthy young adultsClin Infect Dis200234557758211803503 39.BoeckhMThe challenge of respiratory virus" exact="infections" post="in hematopoietic cell transplant recipientsBr J Haematol2008143445546718785968 40.ChienJWet al.Airflow"/>
 <result pre="an immunocompromised patientN Engl J Med2003348986786812606750 43.RaadIAbbasJWhimbeyEInfection control of nosocomial" exact="respiratory" post="viral disease in the immunocompromised hostAm J Med19971023A485210868143 44.ZambonMet"/>
 <result pre="immunocompromised patientN Engl J Med2003348986786812606750 43.RaadIAbbasJWhimbeyEInfection control of nosocomial respiratory" exact="viral" post="disease in the immunocompromised hostAm J Med19971023A485210868143 44.ZambonMet al.Molecular"/>
 <result pre="patientN Engl J Med2003348986786812606750 43.RaadIAbbasJWhimbeyEInfection control of nosocomial respiratory viral" exact="disease" post="in the immunocompromised hostAm J Med19971023A485210868143 44.ZambonMet al.Molecular epidemiology"/>
 <result pre="marrow transplant unitJ Clin Microbiol1998368228922939666007 45.EltingLSet al.Epidemiology of influenza A" exact="virus infection" post="in patients with acute or chronic leukemiaSupport Care Cancer1995331982027655781"/>
 <result pre="transplant unitJ Clin Microbiol1998368228922939666007 45.EltingLSet al.Epidemiology of influenza A virus" exact="infection" post="in patients with acute or chronic leukemiaSupport Care Cancer1995331982027655781"/>
 <result pre="45.EltingLSet al.Epidemiology of influenza A virus infection in patients with" exact="acute" post="or chronic leukemiaSupport Care Cancer1995331982027655781 46.HarringtonRDet al.An outbreak of"/>
 <result pre="al.Epidemiology of influenza A virus infection in patients with acute" exact="or chronic" post="leukemiaSupport Care Cancer1995331982027655781 46.HarringtonRDet al.An outbreak of respiratory syncytial"/>
 <result pre="of influenza A virus infection in patients with acute or" exact="chronic" post="leukemiaSupport Care Cancer1995331982027655781 46.HarringtonRDet al.An outbreak of respiratory syncytial"/>
 <result pre="acute or chronic leukemiaSupport Care Cancer1995331982027655781 46.HarringtonRDet al.An outbreak of" exact="respiratory" post="syncytial virus in a bone marrow transplant centerJ Infect"/>
 <result pre="a bone marrow transplant centerJ Infect Dis199216569879931583345 47.KhannaNet al.Respiratory syncytial" exact="virus infection" post="in patients with hematological diseases: single-center study and review"/>
 <result pre="bone marrow transplant centerJ Infect Dis199216569879931583345 47.KhannaNet al.Respiratory syncytial virus" exact="infection" post="in patients with hematological diseases: single-center study and review"/>
 <result pre="review of the literatureClin Infect Dis200846340241218181739 48.WhimbeyEet al.Respiratory syncytial virus" exact="pneumonia" post="in hospitalized adult patients with leukemiaClin Infect Dis19952123763798562747 49.WhimbeyEet"/>
 <result pre="literatureClin Infect Dis200846340241218181739 48.WhimbeyEet al.Respiratory syncytial virus pneumonia in hospitalized" exact="adult" post="patients with leukemiaClin Infect Dis19952123763798562747 49.WhimbeyEet al.Influenza A virus"/>
 <result pre="adult patients with leukemiaClin Infect Dis19952123763798562747 49.WhimbeyEet al.Influenza A virus" exact="infections" post="among hospitalized adult bone marrow transplant recipientsBone Marrow Transplant19941344374408019468"/>
 <result pre="leukemiaClin Infect Dis19952123763798562747 49.WhimbeyEet al.Influenza A virus infections among hospitalized" exact="adult" post="bone marrow transplant recipientsBone Marrow Transplant19941344374408019468 50.YousufHMet al.Influenza among"/>
 <result pre="hospitalized adults with leukemiaClin Infect Dis1997246109510999195063 51.Ladisla B (1996) Community" exact="respiratory" post="virus infections in hospitalized adult patients with leukemia. In:"/>
 <result pre="with leukemiaClin Infect Dis1997246109510999195063 51.Ladisla B (1996) Community respiratory virus" exact="infections" post="in hospitalized adult patients with leukemia. In: Abstract of"/>
 <result pre="Dis1997246109510999195063 51.Ladisla B (1996) Community respiratory virus infections in hospitalized" exact="adult" post="patients with leukemia. In: Abstract of the Infectious Diseases"/>
 <result pre="in hospitalized adult patients with leukemia. In: Abstract of the" exact="Infectious" post="Diseases Society of America, 1996, New Orleans, Louisiana, p."/>
 <result pre="hospitalized adult patients with leukemia. In: Abstract of the Infectious" exact="Diseases" post="Society of America, 1996, New Orleans, Louisiana, p. Abstract"/>
 <result pre="1996, New Orleans, Louisiana, p. Abstract No. 99 52.WhimbeyEet al.Community" exact="respiratory" post="virus infections among hospitalized adult bone marrow transplant recipientsClin"/>
 <result pre="Orleans, Louisiana, p. Abstract No. 99 52.WhimbeyEet al.Community respiratory virus" exact="infections" post="among hospitalized adult bone marrow transplant recipientsClin Infect Dis19962257787828722930"/>
 <result pre="Abstract No. 99 52.WhimbeyEet al.Community respiratory virus infections among hospitalized" exact="adult" post="bone marrow transplant recipientsClin Infect Dis19962257787828722930 53.WhimbeyEEnglundJACouchRBCommunity respiratory virus"/>
 <result pre="among hospitalized adult bone marrow transplant recipientsClin Infect Dis19962257787828722930 53.WhimbeyEEnglundJACouchRBCommunity" exact="respiratory" post="virus infections in immunocompromised patients with cancerAm J Med19971023A101810868137"/>
 <result pre="adult bone marrow transplant recipientsClin Infect Dis19962257787828722930 53.WhimbeyEEnglundJACouchRBCommunity respiratory virus" exact="infections" post="in immunocompromised patients with cancerAm J Med19971023A101810868137 54.Sivadon-TardyVet al.Guillain-Barre"/>
 <result pre="infections in immunocompromised patients with cancerAm J Med19971023A101810868137 54.Sivadon-TardyVet al.Guillain-Barre" exact="syndrome" post="and influenza virus infectionClin Infect Dis2009481485619025491 55.FalseyARet al.Respiratory syncytial"/>
 <result pre="infectionClin Infect Dis2009481485619025491 55.FalseyARet al.Respiratory syncytial virus and influenza A" exact="infections" post="in the hospitalized elderlyJ Infect Dis199517223893947622882 56.YuiIet al.Detection of"/>
 <result pre="in the hospitalized elderlyJ Infect Dis199517223893947622882 56.YuiIet al.Detection of human" exact="respiratory" post="syncytial virus sequences in peripheral blood mononuclear cellsJ Med"/>
 <result pre="Dis199517223893947622882 56.YuiIet al.Detection of human respiratory syncytial virus sequences in" exact="peripheral" post="blood mononuclear cellsJ Med Virol200370348148912767015 57.NicholsWGGooleyTBoeckhMCommunity-acquired respiratory syncytial virus"/>
 <result pre="virus sequences in peripheral blood mononuclear cellsJ Med Virol200370348148912767015 57.NicholsWGGooleyTBoeckhMCommunity-acquired" exact="respiratory" post="syncytial virus and parainfluenza virus infections after hematopoietic stem"/>
 <result pre="cellsJ Med Virol200370348148912767015 57.NicholsWGGooleyTBoeckhMCommunity-acquired respiratory syncytial virus and parainfluenza virus" exact="infections" post="after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer"/>
 <result pre="virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson" exact="Cancer" post="Research Center experienceBiol Blood Marrow Transplant20017Suppl11S15S11777098 58.HenricksonKJParainfluenza virusesClin Microbiol"/>
 <result pre="stem cell transplantation: the Fred Hutchinson Cancer Research Center experienceBiol" exact="Blood" post="Marrow Transplant20017Suppl11S15S11777098 58.HenricksonKJParainfluenza virusesClin Microbiol Rev200316224226412692097 59.CanePAet al.Human metapneumovirus"/>
 <result pre="metapneumovirus in a haematopoietic stem cell transplant recipient with fatal" exact="lower" post="respiratory tract diseaseBone Marrow Transplant200331430931012621469 60.EnglundJAet al.Brief communication: fatal"/>
 <result pre="in a haematopoietic stem cell transplant recipient with fatal lower" exact="respiratory" post="tract diseaseBone Marrow Transplant200331430931012621469 60.EnglundJAet al.Brief communication: fatal human"/>
 <result pre="respiratory tract diseaseBone Marrow Transplant200331430931012621469 60.EnglundJAet al.Brief communication: fatal human" exact="metapneumovirus infection" post="in stem-cell transplant recipientsAnn Intern Med2006144534434916520475 61.PelletierGet al.Respiratory tract"/>
 <result pre="tract diseaseBone Marrow Transplant200331430931012621469 60.EnglundJAet al.Brief communication: fatal human metapneumovirus" exact="infection" post="in stem-cell transplant recipientsAnn Intern Med2006144534434916520475 61.PelletierGet al.Respiratory tract"/>
 <result pre="an immunocompromised childEmerg Infect Dis20028997697812194777 62.KambojMet al.Clinical characterization of human" exact="metapneumovirus infection" post="among patients with cancerJ Infect200857646447119027169 63.OliveiraRet al.Frequency of human"/>
 <result pre="immunocompromised childEmerg Infect Dis20028997697812194777 62.KambojMet al.Clinical characterization of human metapneumovirus" exact="infection" post="among patients with cancerJ Infect200857646447119027169 63.OliveiraRet al.Frequency of human"/>
 <result pre="infection among patients with cancerJ Infect200857646447119027169 63.OliveiraRet al.Frequency of human" exact="metapneumovirus infection" post="in hematopoietic SCT recipients during 3 consecutive yearsBone Marrow"/>
 <result pre="among patients with cancerJ Infect200857646447119027169 63.OliveiraRet al.Frequency of human metapneumovirus" exact="infection" post="in hematopoietic SCT recipients during 3 consecutive yearsBone Marrow"/>
 <result pre="Transplant200842426526918516078 64.WilliamsJVet al.A prospective study comparing human metapneumovirus with other" exact="respiratory" post="viruses in adults with hematologic malignancies and respiratory tract"/>
 <result pre="with other respiratory viruses in adults with hematologic malignancies and" exact="respiratory" post="tract infectionsJ Infect Dis200519261061106516107960 65.DebiaggiMet al.Long-term study on symptomless"/>
 <result pre="tract infectionsJ Infect Dis200519261061106516107960 65.DebiaggiMet al.Long-term study on symptomless human" exact="metapneumovirus infection" post="in hematopoietic stem cell transplant recipientsNew Microbiol200730325525817802904 66.KaidaAet al.Seasonal"/>
 <result pre="infectionsJ Infect Dis200519261061106516107960 65.DebiaggiMet al.Long-term study on symptomless human metapneumovirus" exact="infection" post="in hematopoietic stem cell transplant recipientsNew Microbiol200730325525817802904 66.KaidaAet al.Seasonal"/>
 <result pre="Osaka City, JapanJ Clin Virol200635439439916460998 67.SchildgenOet al.Human metapneumovirus RNA in" exact="encephalitis" post="patientEmerg Infect Dis200511346747015757568 68.NicholsonKGet al.Risk factors for lower respiratory"/>
 <result pre="RNA in encephalitis patientEmerg Infect Dis200511346747015757568 68.NicholsonKGet al.Risk factors for" exact="lower" post="respiratory complications of rhinovirus infections in elderly people living"/>
 <result pre="in encephalitis patientEmerg Infect Dis200511346747015757568 68.NicholsonKGet al.Risk factors for lower" exact="respiratory" post="complications of rhinovirus infections in elderly people living in"/>
 <result pre="Dis200511346747015757568 68.NicholsonKGet al.Risk factors for lower respiratory complications of rhinovirus" exact="infections" post="in elderly people living in the community: prospective cohort"/>
 <result pre="living in the community: prospective cohort studyBMJ19963137065111911238916700 69.PapadopoulosNGDo rhinoviruses cause" exact="pneumonia" post="in children?Paediatr Respir Rev20045Suppl AS191S19514980269 70.HaydenFGRhinovirus and the lower"/>
 <result pre="cause pneumonia in children?Paediatr Respir Rev20045Suppl AS191S19514980269 70.HaydenFGRhinovirus and the" exact="lower" post="respiratory tractRev Med Virol2004141173114716689 71.PapadopoulosNGet al.Rhinoviruses infect the lower"/>
 <result pre="pneumonia in children?Paediatr Respir Rev20045Suppl AS191S19514980269 70.HaydenFGRhinovirus and the lower" exact="respiratory" post="tractRev Med Virol2004141173114716689 71.PapadopoulosNGet al.Rhinoviruses infect the lower airwaysJ"/>
 <result pre="the lower respiratory tractRev Med Virol2004141173114716689 71.PapadopoulosNGet al.Rhinoviruses infect the" exact="lower" post="airwaysJ Infect Dis200018161875188410837165 72.KaiserLHaydenFGEditorial response: rhinovirus pneumonia–a clinical entity?Clin"/>
 <result pre="72.KaiserLHaydenFGEditorial response: rhinovirus pneumonia–a clinical entity?Clin Infect Dis199929353353510530442 73.GhoshSet al.Rhinovirus" exact="infections" post="in myelosuppressed adult blood and marrow transplant recipientsClin Infect"/>
 <result pre="pneumonia–a clinical entity?Clin Infect Dis199929353353510530442 73.GhoshSet al.Rhinovirus infections in myelosuppressed" exact="adult" post="blood and marrow transplant recipientsClin Infect Dis199929352853210530441 74.GutmanJAet al.Rhinovirus"/>
 <result pre="recipientsClin Infect Dis199929352853210530441 74.GutmanJAet al.Rhinovirus as a cause of fatal" exact="lower" post="respiratory tract infection in adult stem cell transplantation patients:"/>
 <result pre="Infect Dis199929352853210530441 74.GutmanJAet al.Rhinovirus as a cause of fatal lower" exact="respiratory" post="tract infection in adult stem cell transplantation patients: a"/>
 <result pre="74.GutmanJAet al.Rhinovirus as a cause of fatal lower respiratory tract" exact="infection" post="in adult stem cell transplantation patients: a report of"/>
 <result pre="as a cause of fatal lower respiratory tract infection in" exact="adult" post="stem cell transplantation patients: a report of two casesBone"/>
 <result pre="Transplant200740880981117704788 75.ImakitaMet al.Pneumonia caused by rhinovirusClin Infect Dis200030361161210722460 76.IsonMGet al.Rhinovirus" exact="infections" post="in hematopoietic stem cell transplant recipients with pneumoniaClin Infect"/>
 <result pre="cell transplant recipients with pneumoniaClin Infect Dis20033691139114312715308 77.ParodyRet al.Upper and" exact="lower" post="respiratory tract infections by human enterovirus and rhinovirus in"/>
 <result pre="transplant recipients with pneumoniaClin Infect Dis20033691139114312715308 77.ParodyRet al.Upper and lower" exact="respiratory" post="tract infections by human enterovirus and rhinovirus in adult"/>
 <result pre="with pneumoniaClin Infect Dis20033691139114312715308 77.ParodyRet al.Upper and lower respiratory tract" exact="infections" post="by human enterovirus and rhinovirus in adult patients with"/>
 <result pre="lower respiratory tract infections by human enterovirus and rhinovirus in" exact="adult" post="patients with hematological malignanciesAm J Hematol200782980781117563077 78.GonzalezYet al.Pulmonary enterovirus"/>
 <result pre="adult patients with hematological malignanciesAm J Hematol200782980781117563077 78.GonzalezYet al.Pulmonary enterovirus" exact="infections" post="in stem cell transplant recipientsBone Marrow Transplant199923551151310100567 79.GonzalezYet al.Community"/>
 <result pre="infections in stem cell transplant recipientsBone Marrow Transplant199923551151310100567 79.GonzalezYet al.Community" exact="respiratory" post="virus infections in patients with hematologic malignanciesHaematologica199984982082310477456 80.RabellaNet al.Conventional"/>
 <result pre="stem cell transplant recipientsBone Marrow Transplant199923551151310100567 79.GonzalezYet al.Community respiratory virus" exact="infections" post="in patients with hematologic malignanciesHaematologica199984982082310477456 80.RabellaNet al.Conventional respiratory viruses"/>
 <result pre="respiratory virus infections in patients with hematologic malignanciesHaematologica199984982082310477456 80.RabellaNet al.Conventional" exact="respiratory" post="viruses recovered from immunocompromised patients: clinical considerationsClin Infect Dis19992851043104810452632"/>
 <result pre="recent advances in coronavirus discoveryPediatr Infect Dis J20052411 SupplS223S22716378050 82.FolzRJElkordyMACoronavirus" exact="pneumonia" post="following autologous bone marrow transplantation for breast cancerChest1999115390190510084516 83.PeneFet"/>
 <result pre="J20052411 SupplS223S22716378050 82.FolzRJElkordyMACoronavirus pneumonia following autologous bone marrow transplantation for" exact="breast" post="cancerChest1999115390190510084516 83.PeneFet al.Coronavirus 229E-related pneumonia in immunocompromised patientsClin Infect"/>
 <result pre="autologous bone marrow transplantation for breast cancerChest1999115390190510084516 83.PeneFet al.Coronavirus 229E-related" exact="pneumonia" post="in immunocompromised patientsClin Infect Dis200337792993213130404 84.ErardVet al.Airflow decline after"/>
 <result pre="after myeloablative allogeneic hematopoietic cell transplantation: the role of community" exact="respiratory" post="virusesJ Infect Dis2006193121619162516703503 85.WalterMJet al.Viral induction of a chronic"/>
 <result pre="community respiratory virusesJ Infect Dis2006193121619162516703503 85.WalterMJet al.Viral induction of a" exact="chronic" post="asthma phenotype and genetic segregation from the acute responseJ"/>
 <result pre="respiratory virusesJ Infect Dis2006193121619162516703503 85.WalterMJet al.Viral induction of a chronic" exact="asthma" post="phenotype and genetic segregation from the acute responseJ Clin"/>
 <result pre="of a chronic asthma phenotype and genetic segregation from the" exact="acute" post="responseJ Clin Invest2002110216517512122108 86.ChakrabartiSet al.Adenovirus infections following allogeneic stem"/>
 <result pre="genetic segregation from the acute responseJ Clin Invest2002110216517512122108 86.ChakrabartiSet al.Adenovirus" exact="infections" post="following allogeneic stem cell transplantation: incidence and outcome in"/>
 <result pre="manipulation, immunosuppression, and immune recoveryBlood200210051619162712176880 87.FlomenbergPet al.Increasing incidence of adenovirus" exact="disease" post="in bone marrow transplant recipientsJ Infect Dis199416947757818133091 88.HowardDSet al.Adenovirus"/>
 <result pre="disease in bone marrow transplant recipientsJ Infect Dis199416947757818133091 88.HowardDSet al.Adenovirus" exact="infections" post="in hematopoietic stem cell transplant recipientsClin Infect Dis19992961494150110585802 89.La"/>
 <result pre="hematopoietic stem cell transplant recipientsClin Infect Dis19992961494150110585802 89.La RosaAMet al.Adenovirus" exact="infections" post="in adult recipients of blood and marrow transplantsClin Infect"/>
 <result pre="cell transplant recipientsClin Infect Dis19992961494150110585802 89.La RosaAMet al.Adenovirus infections in" exact="adult" post="recipients of blood and marrow transplantsClin Infect Dis200132687187611247710 90.BaldwinAet"/>
 <result pre="90.BaldwinAet al.Outcome and clinical course of 100 patients with adenovirus" exact="infection" post="following bone marrow transplantationBone Marrow Transplant200026121333133811223974 91.LionTet al.Molecular monitoring"/>
 <result pre="marrow transplantationBone Marrow Transplant200026121333133811223974 91.LionTet al.Molecular monitoring of adenovirus in" exact="peripheral" post="blood after allogeneic bone marrow transplantation permits early diagnosis"/>
 <result pre="diagnosis of disseminated diseaseBlood200310231114112012702513 92.EchavarriaMet al.Prediction of severe disseminated adenovirus" exact="infection" post="by serum PCRLancet2001358927938438511502321 93.ErardVet al.Quantitative real-time polymerase chain reaction"/>
 <result pre="for detection of adenovirus after T cell-replete hematopoietic cell transplantation:" exact="viral" post="load as a marker for invasive diseaseClin Infect Dis200745895896517879908"/>
 <result pre="adenovirus DNA in serum correlate with fatal outcome of adenovirus" exact="infection" post="in children after allogeneic stem-cell transplantationClin Infect Dis200235552653212173125 95.BrunoBet"/>
 <result pre="in children after allogeneic stem-cell transplantationClin Infect Dis200235552653212173125 95.BrunoBet al.Adenovirus" exact="infection" post="in hematopoietic stem cell transplantation: effect of ganciclovir and"/>
 <result pre="stem cell transplantation: effect of ganciclovir and impact on survivalBiol" exact="Blood" post="Marrow Transplant20039534135212766884 96.HaleGAet al.Adenovirus infection after pediatric bone marrow"/>
 <result pre="ganciclovir and impact on survivalBiol Blood Marrow Transplant20039534135212766884 96.HaleGAet al.Adenovirus" exact="infection" post="after pediatric bone marrow transplantationBone Marrow Transplant199923327728210084260 97.BrunoBet al.Adenovirus"/>
 <result pre="infection after pediatric bone marrow transplantationBone Marrow Transplant199923327728210084260 97.BrunoBet al.Adenovirus" exact="nephritis" post="in hematopoietic stem-cell transplantationTransplantation20047771049105715087771 98.CoxGJet al.Etiology and outcome of"/>
 <result pre="nephritis in hematopoietic stem-cell transplantationTransplantation20047771049105715087771 98.CoxGJet al.Etiology and outcome of" exact="diarrhea" post="after marrow transplantation: a prospective studyGastroenterology19941075139814077926504 99.GlezenWPet al.Impact of"/>
 <result pre="diarrhea after marrow transplantation: a prospective studyGastroenterology19941075139814077926504 99.GlezenWPet al.Impact of" exact="respiratory" post="virus infections on persons with chronic underlying conditionsJAMA2000283449950510659876 100.BarenfangerJet"/>
 <result pre="marrow transplantation: a prospective studyGastroenterology19941075139814077926504 99.GlezenWPet al.Impact of respiratory virus" exact="infections" post="on persons with chronic underlying conditionsJAMA2000283449950510659876 100.BarenfangerJet al.Clinical and"/>
 <result pre="studyGastroenterology19941075139814077926504 99.GlezenWPet al.Impact of respiratory virus infections on persons with" exact="chronic" post="underlying conditionsJAMA2000283449950510659876 100.BarenfangerJet al.Clinical and financial benefits of rapid"/>
 <result pre="conditionsJAMA2000283449950510659876 100.BarenfangerJet al.Clinical and financial benefits of rapid detection of" exact="respiratory" post="viruses: an outcomes studyJ Clin Microbiol20003882824282810921934 101.WooPCet al.Cost-effectiveness of"/>
 <result pre="outcomes studyJ Clin Microbiol20003882824282810921934 101.WooPCet al.Cost-effectiveness of rapid diagnosis of" exact="viral" post="respiratory tract infections in pediatric patientsJ Clin Microbiol1997356157915819163486 102.Singh-NazNBrownMGaneshananthanMNosocomial"/>
 <result pre="studyJ Clin Microbiol20003882824282810921934 101.WooPCet al.Cost-effectiveness of rapid diagnosis of viral" exact="respiratory" post="tract infections in pediatric patientsJ Clin Microbiol1997356157915819163486 102.Singh-NazNBrownMGaneshananthanMNosocomial adenovirus"/>
 <result pre="Microbiol20003882824282810921934 101.WooPCet al.Cost-effectiveness of rapid diagnosis of viral respiratory tract" exact="infections" post="in pediatric patientsJ Clin Microbiol1997356157915819163486 102.Singh-NazNBrownMGaneshananthanMNosocomial adenovirus infection: molecular"/>
 <result pre="J199312119229258265282 103.HeikkinenTet al.Nasal swab versus nasopharyngeal aspirate for isolation of" exact="respiratory" post="virusesJ Clin Microbiol200240114337433912409425 104.StensballeLGet al.Comparison of nasopharyngeal aspirate and"/>
 <result pre="of nasopharyngeal aspirate and nasal swab specimens for detection of" exact="respiratory" post="syncytial virus in different settings in a developing countryTrop"/>
 <result pre="pernasal flocked swabs and nasopharyngeal aspirates for detection of common" exact="respiratory" post="viruses in samples from childrenJ Clin Microbiol20084672414241718480225 106.DaleyPet al.Comparison"/>
 <result pre="106.DaleyPet al.Comparison of flocked and rayon swabs for collection of" exact="respiratory" post="epithelial cells from uninfected volunteers and symptomatic patientsJ Clin"/>
 <result pre="al.Comparison of flocked and rayon swabs for collection of respiratory" exact="epithelial" post="cells from uninfected volunteers and symptomatic patientsJ Clin Microbiol20064462265226716757636"/>
 <result pre="for collection of respiratory epithelial cells from uninfected volunteers and" exact="symptomatic" post="patientsJ Clin Microbiol20064462265226716757636 107.GunsonRNCollinsTCCarmanWFReal-time RT-PCR detection of 12 respiratory"/>
 <result pre="and symptomatic patientsJ Clin Microbiol20064462265226716757636 107.GunsonRNCollinsTCCarmanWFReal-time RT-PCR detection of 12" exact="respiratory" post="viral infections in four triplex reactionsJ Clin Virol200533434134415927526 108.LegoffJet"/>
 <result pre="symptomatic patientsJ Clin Microbiol20064462265226716757636 107.GunsonRNCollinsTCCarmanWFReal-time RT-PCR detection of 12 respiratory" exact="viral" post="infections in four triplex reactionsJ Clin Virol200533434134415927526 108.LegoffJet al.Evaluation"/>
 <result pre="patientsJ Clin Microbiol20064462265226716757636 107.GunsonRNCollinsTCCarmanWFReal-time RT-PCR detection of 12 respiratory viral" exact="infections" post="in four triplex reactionsJ Clin Virol200533434134415927526 108.LegoffJet al.Evaluation of"/>
 <result pre="for detection of influenza A and influenza B viruses and" exact="respiratory" post="syncytial viruses in childrenJ Clin Microbiol200846278979118057126 109.MarkoulatosPSiafakasNMoncanyMMultiplex polymerase chain"/>
 <result pre="and sensitive method using multiplex real-time PCR for diagnosis of" exact="infections" post="by influenza a and influenza B viruses, respiratory syncytial"/>
 <result pre="diagnosis of infections by influenza a and influenza B viruses," exact="respiratory" post="syncytial virus, and parainfluenza viruses 1, 2, 3, and"/>
 <result pre="4J Clin Microbiol20044241564156915071005 111.GrondahlBet al.Rapid identification of nine microorganisms causing" exact="acute" post="respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility"/>
 <result pre="Clin Microbiol20044241564156915071005 111.GrondahlBet al.Rapid identification of nine microorganisms causing acute" exact="respiratory" post="tract infections by single-tube multiplex reverse transcription-PCR: feasibility studyJ"/>
 <result pre="111.GrondahlBet al.Rapid identification of nine microorganisms causing acute respiratory tract" exact="infections" post="by single-tube multiplex reverse transcription-PCR: feasibility studyJ Clin Microbiol1999371179854054"/>
 <result pre="reverse transcription-PCR: feasibility studyJ Clin Microbiol1999371179854054 112.LegoffJet al.High prevalence of" exact="respiratory" post="viral infections in patients hospitalized in an intensive care"/>
 <result pre="transcription-PCR: feasibility studyJ Clin Microbiol1999371179854054 112.LegoffJet al.High prevalence of respiratory" exact="viral" post="infections in patients hospitalized in an intensive care unit"/>
 <result pre="feasibility studyJ Clin Microbiol1999371179854054 112.LegoffJet al.High prevalence of respiratory viral" exact="infections" post="in patients hospitalized in an intensive care unit for"/>
 <result pre="infections in patients hospitalized in an intensive care unit for" exact="acute" post="respiratory infections as detected by nucleic acid-based assaysJ Clin"/>
 <result pre="in patients hospitalized in an intensive care unit for acute" exact="respiratory" post="infections as detected by nucleic acid-based assaysJ Clin Microbiol200543145545715635014"/>
 <result pre="patients hospitalized in an intensive care unit for acute respiratory" exact="infections" post="as detected by nucleic acid-based assaysJ Clin Microbiol200543145545715635014 113.LioliosLet"/>
 <result pre="al.Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional" exact="viral" post="culture and immunofluorescence techniques for the detection of seven"/>
 <result pre="viral culture and immunofluorescence techniques for the detection of seven" exact="viral" post="respiratory pathogensJ Clin Microbiol20013982779278311473991 114.CannonGAet al.A low density oligonucleotide"/>
 <result pre="culture and immunofluorescence techniques for the detection of seven viral" exact="respiratory" post="pathogensJ Clin Microbiol20013982779278311473991 114.CannonGAet al.A low density oligonucleotide microarray"/>
 <result pre="114.CannonGAet al.A low density oligonucleotide microarray for the detection of" exact="viral" post="and atypical bacterial respiratory pathogensJ Virol Methods20101631172419638287 115.LiHet al.Simultaneous"/>
 <result pre="low density oligonucleotide microarray for the detection of viral and" exact="atypical" post="bacterial respiratory pathogensJ Virol Methods20101631172419638287 115.LiHet al.Simultaneous detection and"/>
 <result pre="density oligonucleotide microarray for the detection of viral and atypical" exact="bacterial" post="respiratory pathogensJ Virol Methods20101631172419638287 115.LiHet al.Simultaneous detection and high-throughput"/>
 <result pre="oligonucleotide microarray for the detection of viral and atypical bacterial" exact="respiratory" post="pathogensJ Virol Methods20101631172419638287 115.LiHet al.Simultaneous detection and high-throughput identification"/>
 <result pre="and high-throughput identification of a panel of RNA viruses causing" exact="respiratory" post="tract infectionsJ Clin Microbiol20074572105210917507510 116.PabbarajuKet al.Comparison of the Luminex"/>
 <result pre="tract infectionsJ Clin Microbiol20074572105210917507510 116.PabbarajuKet al.Comparison of the Luminex xTAG" exact="respiratory" post="viral panel with in-house nucleic acid amplification tests for"/>
 <result pre="infectionsJ Clin Microbiol20074572105210917507510 116.PabbarajuKet al.Comparison of the Luminex xTAG respiratory" exact="viral" post="panel with in-house nucleic acid amplification tests for diagnosis"/>
 <result pre="panel with in-house nucleic acid amplification tests for diagnosis of" exact="respiratory" post="virus infectionsJ Clin Microbiol20084693056306218632902 117.DominguezSRet al.Multiplex MassTag-PCR for respiratory"/>
 <result pre="of respiratory virus infectionsJ Clin Microbiol20084693056306218632902 117.DominguezSRet al.Multiplex MassTag-PCR for" exact="respiratory" post="pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic"/>
 <result pre="118.ReijansMet al.RespiFinder: a new multiparameter test to differentially identify fifteen" exact="respiratory" post="virusesJ Clin Microbiol20084641232124018256230 119.SampathRet al.Global surveillance of emerging Influenza"/>
 <result pre="spectrometryPLoS ONE200725e48917534439 120.KuypersJet al.Comparison of conventional and molecular detection of" exact="respiratory" post="viruses in hematopoietic cell transplant recipientsTranspl Infect Dis200911429830319453994 121.Jefferson"/>
 <result pre="infectionsLancet19983529144187718819863784 124.NicholsonKGet al.Efficacy and safety of oseltamivir in treatment of" exact="acute" post="influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment"/>
 <result pre="and safety of the oral neuraminidase inhibitor oseltamivir in treating" exact="acute" post="influenza: a randomised controlled trial. US Oral Neuraminidase Study"/>
 <result pre="132.WhimbeyEet al.Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for" exact="respiratory" post="syncytial virus disease in adult bone marrow transplant recipientsBone"/>
 <result pre="with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus" exact="disease" post="in adult bone marrow transplant recipientsBone Marrow Transplant19951633933998535312 133.BoeckhMet"/>
 <result pre="ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in" exact="adult" post="bone marrow transplant recipientsBone Marrow Transplant19951633933998535312 133.BoeckhMet al.Randomized controlled"/>
 <result pre="Transplant19951633933998535312 133.BoeckhMet al.Randomized controlled multicenter trial of aerosolized ribavirin for" exact="respiratory" post="syncytial virus upper respiratory tract infection in hematopoietic cell"/>
 <result pre="controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus" exact="upper respiratory tract infection" post="in hematopoietic cell transplant recipientsClin Infect Dis200744224524917173225 134.GhoshSet al.Respiratory"/>
 <result pre="multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper" exact="respiratory" post="tract infection in hematopoietic cell transplant recipientsClin Infect Dis200744224524917173225"/>
 <result pre="of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract" exact="infection" post="in hematopoietic cell transplant recipientsClin Infect Dis200744224524917173225 134.GhoshSet al.Respiratory"/>
 <result pre="hematopoietic cell transplant recipientsClin Infect Dis200744224524917173225 134.GhoshSet al.Respiratory syncytial virus" exact="infections" post="in autologous blood and marrow transplant recipients with breast"/>
 <result pre="virus infections in autologous blood and marrow transplant recipients with" exact="breast" post="cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulinsBone"/>
 <result pre="Transplant200128327127511535995 135.LewinsohnDMet al.Phase I study of intravenous ribavirin treatment of" exact="respiratory" post="syncytial virus pneumonia after marrow transplantationAntimicrob Agents Chemother19964011255525578913463 136.DeVincenzoJPet"/>
 <result pre="I study of intravenous ribavirin treatment of respiratory syncytial virus" exact="pneumonia" post="after marrow transplantationAntimicrob Agents Chemother19964011255525578913463 136.DeVincenzoJPet al.Respiratory syncytial virus"/>
 <result pre="Agents Chemother19964011255525578913463 136.DeVincenzoJPet al.Respiratory syncytial virus immune globulin treatment of" exact="lower" post="respiratory tract infection in pediatric patients undergoing bone marrow"/>
 <result pre="Chemother19964011255525578913463 136.DeVincenzoJPet al.Respiratory syncytial virus immune globulin treatment of lower" exact="respiratory" post="tract infection in pediatric patients undergoing bone marrow transplantation"/>
 <result pre="al.Respiratory syncytial virus immune globulin treatment of lower respiratory tract" exact="infection" post="in pediatric patients undergoing bone marrow transplantation - a"/>
 <result pre="a compassionate use experienceBone Marrow Transplant200025216116510673674 137.GhoshSet al.Respiratory syncytial virus" exact="upper" post="respiratory tract illnesses in adult blood and marrow transplant"/>
 <result pre="compassionate use experienceBone Marrow Transplant200025216116510673674 137.GhoshSet al.Respiratory syncytial virus upper" exact="respiratory" post="tract illnesses in adult blood and marrow transplant recipients:"/>
 <result pre="Transplant200025216116510673674 137.GhoshSet al.Respiratory syncytial virus upper respiratory tract illnesses in" exact="adult" post="blood and marrow transplant recipients: combination therapy with aerosolized"/>
 <result pre="intravenous immunoglobulinBone Marrow Transplant200025775175510745261 138.BoeckhMet al.Phase 1 evaluation of the" exact="respiratory" post="syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic"/>
 <result pre="of hematopoietic stem cell transplantsJ Infect Dis2001184335035411443562 139.NicholsWGet al.Parainfluenza virus" exact="infections" post="after hematopoietic stem cell transplantation: risk factors, response to"/>
 <result pre="antiviral therapy, and effect on transplant outcomeBlood200198357357811468152 140.ChakrabartiSet al.Parainfluenza virus" exact="type 3" post="infections in hematopoetic stem cell transplant recipients: response to"/>
 <result pre="and effect on transplant outcomeBlood200198357357811468152 140.ChakrabartiSet al.Parainfluenza virus type 3" exact="infections" post="in hematopoetic stem cell transplant recipients: response to ribavirin"/>
 <result pre="Dis20003161516151811096028 141.WydePRet al.Comparison of the inhibition of human metapneumovirus and" exact="respiratory" post="syncytial virus by ribavirin and immune serum globulin in"/>
 <result pre="immune serum globulin in vitroAntiviral Res2003601515914516921 142.BordigoniPet al.Treatment of adenovirus" exact="infections" post="in patients undergoing allogeneic hematopoietic stem cell transplantationClin Infect"/>
 <result pre="allogeneic hematopoietic stem cell transplantationClin Infect Dis20013291290129711303263 143.ChakrabartiSet al.Fulminant adenovirus" exact="hepatitis" post="following unrelated bone marrow transplantation: failure of intravenous ribavirin"/>
 <result pre="ribavirin therapyBone Marrow Transplant199923111209121110382964 144.GavinPJKatzBZIntravenous ribavirin treatment for severe adenovirus" exact="disease" post="in immunocompromised childrenPediatrics20021101 Pt 1e912093990 145.LilesWCet al.Severe adenoviral nephritis"/>
 <result pre="adenovirus disease in immunocompromised childrenPediatrics20021101 Pt 1e912093990 145.LilesWCet al.Severe adenoviral" exact="nephritis" post="following bone marrow transplantation: successful treatment with intravenous ribavirinBone"/>
 <result pre="al.Failure of intravenous ribavirin in the treatment of invasive adenovirus" exact="infection" post="following allogeneic bone marrow transplantation: a case reportJ Infect19983622272289570662"/>
 <result pre="case reportJ Infect19983622272289570662 147.MiyamuraKet al.Successful ribavirin therapy for severe adenovirus" exact="hemorrhagic cystitis" post="after allogeneic marrow transplant from close HLA donors rather"/>
 <result pre="reportJ Infect19983622272289570662 147.MiyamuraKet al.Successful ribavirin therapy for severe adenovirus hemorrhagic" exact="cystitis" post="after allogeneic marrow transplant from close HLA donors rather"/>
 <result pre="HLA donors rather than distant donorsBone Marrow Transplant200025554554810713633 148.HoffmanJAet al.Adenoviral" exact="infections" post="and a prospective trial of cidofovir in pediatric hematopoietic"/>
 <result pre="prospective trial of cidofovir in pediatric hematopoietic stem cell transplantationBiol" exact="Blood" post="Marrow Transplant20017738839411529489 149.LegrandFet al.Early diagnosis of adenovirus infection and"/>
 <result pre="cell transplantationBiol Blood Marrow Transplant20017738839411529489 149.LegrandFet al.Early diagnosis of adenovirus" exact="infection" post="and treatment with cidofovir after bone marrow transplantation in"/>
 <result pre="marrow transplantation in childrenBone Marrow Transplant200127662162611319592 150.LjungmanPet al.Cidofovir for adenovirus" exact="infections" post="after allogeneic hematopoietic stem cell transplantation: a survey by"/>
 <result pre="after allogeneic hematopoietic stem cell transplantation: a survey by the" exact="Infectious" post="Diseases Working Party of the European Group for Blood"/>
 <result pre="allogeneic hematopoietic stem cell transplantation: a survey by the Infectious" exact="Diseases" post="Working Party of the European Group for Blood and"/>
 <result pre="the Infectious Diseases Working Party of the European Group for" exact="Blood" post="and Marrow TransplantationBone Marrow Transplant200331648148612665844 151.NeofytosDet al.Treatment of adenovirus"/>
 <result pre="Blood and Marrow TransplantationBone Marrow Transplant200331648148612665844 151.NeofytosDet al.Treatment of adenovirus" exact="disease" post="in stem cell transplant recipients with cidofovirBiol Blood Marrow"/>
 <result pre="of adenovirus disease in stem cell transplant recipients with cidofovirBiol" exact="Blood" post="Marrow Transplant2007131748117222755 152.SivaprakasamPet al.Improved outcome from invasive adenovirus infection"/>
 <result pre="cidofovirBiol Blood Marrow Transplant2007131748117222755 152.SivaprakasamPet al.Improved outcome from invasive adenovirus" exact="infection" post="in pediatric patients after hemopoietic stem cell transplantation using"/>
 <result pre="Pediatr Hematol Oncol2007292818517279003 153.YusufUet al.Cidofovir for the treatment of adenoviral" exact="infection" post="in pediatric hematopoietic stem cell transplant patientsTransplantation200681101398140416732176 154.NaesensLet al.Antiadenovirus"/>
 <result pre="classes of nucleoside and nucleotide analoguesAntimicrob Agents Chemother20054931010101615728896 155.ChakrabartiSet al.Adenovirus" exact="infections" post="following haematopoietic cell transplantation: is there a role for"/>
 <result pre="adoptive transfer of virus-specific T-cell immunity for the treatment of" exact="systemic" post="adenovirus infection after allogeneic stem cell transplantationBr J Haematol20061341647616803570"/>
 <result pre="of virus-specific T-cell immunity for the treatment of systemic adenovirus" exact="infection" post="after allogeneic stem cell transplantationBr J Haematol20061341647616803570 157.TeramuraTet al.Quantitative"/>
 <result pre="a transplant recipientLancet20023599321194512057576 158.CortezKJet al.Outbreak of human parainfluenza virus 3" exact="infections" post="in a hematopoietic stem cell transplant populationJ Infect Dis200118491093109711598830"/>
 <result pre="159.KimSet al.Molecular epidemiological investigation of a nosocomial outbreak of human" exact="metapneumovirus infection" post="in a pediatric hemato-oncology patient populationJ Clin Microbiol20094741221122419213698 160.NicholsWGet"/>
 <result pre="al.Molecular epidemiological investigation of a nosocomial outbreak of human metapneumovirus" exact="infection" post="in a pediatric hemato-oncology patient populationJ Clin Microbiol20094741221122419213698 160.NicholsWGet"/>
 <result pre="Clin Microbiol20094741221122419213698 160.NicholsWGet al.Prolonged outbreak of human parainfluenza virus 3" exact="infection" post="in a stem cell transplant outpatient department: insights from"/>
 <result pre="stem cell transplant outpatient department: insights from molecular epidemiologic analysisBiol" exact="Blood" post="Marrow Transplant2004101586414752780 161.DaughertyELet al.The use of personal protective equipment"/>
 <result pre="Med20093741210121619242326 162.SiegelJDet al.2007 Guideline for Isolation Precautions: Preventing Transmission of" exact="Infectious" post="Agents in Health Care SettingsAm J Infect Control20073510 Suppl"/>
 <result pre="and N95 masks to filter influenza virus in patients with" exact="acute" post="influenza infectionClin Infect Dis200949227527719522650 166.LoebMet al.Surgical mask vs N95"/>
 <result pre="to hemagglutinin components of influenza vaccine in patients with non-Hodgkin" exact="malignant" post="lymphomaVaccine20062444–466620662316870313 168.EngelhardDet al.Antibody response to a two-dose regimen of"/>
 <result pre="170.LoWet al.Antibody response to a two-dose influenza vaccine regimen in" exact="adult" post="lymphoma patients on chemotherapyEur J Clin Microbiol Infect Dis199312107787828307050"/>
 <result pre="al.Antibody response to a two-dose influenza vaccine regimen in adult" exact="lymphoma" post="patients on chemotherapyEur J Clin Microbiol Infect Dis199312107787828307050 171.OrtbalsDWet"/>
 <result pre="chemotherapyEur J Clin Microbiol Infect Dis199312107787828307050 171.OrtbalsDWet al.Influenza immunization of" exact="adult" post="patients with malignant diseasesAnn Intern Med1977875552557921082 172.PauksenKet al.Granulocyte-macrophage colony-stimulating"/>
 <result pre="Microbiol Infect Dis199312107787828307050 171.OrtbalsDWet al.Influenza immunization of adult patients with" exact="malignant" post="diseasesAnn Intern Med1977875552557921082 172.PauksenKet al.Granulocyte-macrophage colony-stimulating factor as immunomodulating"/>
 <result pre="174.LjungmanPet al.Vaccination of stem cell transplant recipients: recommendations of the" exact="Infectious" post="Diseases Working Party of the EBMTBone Marrow Transplant200535873774615750612 175.SalgadoCDet"/>
 <result pre="al.Vaccination of stem cell transplant recipients: recommendations of the Infectious" exact="Diseases" post="Working Party of the EBMTBone Marrow Transplant200535873774615750612 175.SalgadoCDet al.Preventing"/>
 <result pre="cell transplant recipients: a retrospective case-control studyClin Infect Dis200745218719317578777 178.PeckAJCoreyLBoeckhMPretransplantation" exact="respiratory" post="syncytial virus infection: impact of a strategy to delay"/>
</results>
